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93 ABSTRACT
With the growing obesity epidemic and associated metabolic comorbidity, molecular
insights into the regulation of body fat are needed to facilitate the development of new
therapeutic avenues. Cells store excess energy mostly as neutral lipids (NLs), inside
fat-specialized organelles called lipid droplets (LDs). Recent research has revealed
LDs to be metabolic hubs involved in many cellular processes, such as lipid
metabolism, protein degradation and endoplasmic reticulum (ER) homeostasis. There
is also increasing evidence for links between LD biology and many human
pathologies, including cardiovascular disease, cancer progression and non-alcoholic
fatty liver diseases. Thus, detailed understanding of LD biology should be beneficial
for tackling these disease states.
LDs are intracellular storage organelles consisting of a core of NLs surrounded by a
phospholipid monolayer. Their biogenesis begins in the ER, with accumulation of NL
lenses within the ER bilayer that subsequently grow and bud into the cytosol as distinct
organelles. This process is thought to occur in specialized ER subdomains with a
unique lipid and protein composition, but a detailed understanding of the earliest steps
of LD biogenesis is still lacking. After formation, LDs retain an intimate relationship
with their mother organelle, the ER, through ER-LD contacts. Deciphering the
functionalities and topological features of these specialized membrane contact sites is
crucial for understanding LD biology.
Seipin is an oligomeric ER transmembrane protein implicated in LD assembly, ER-
LD contacts and adipocyte development. Mutations in seipin give rise to three disease
states in humans: a severe form of congenital lipodystrophy (BSCL2), a motor neuron
disease called seipinopathy and a fatal neurodegenerative disease called Celia’s
encephalopathy. Work from various model systems has shown seipin to be crucial for
LD biogenesis, and seipin has been found to localize at ER-LD contacts in yeast cells.
In addition, disruption of seipin function halts the adipogenic differentiation
programme at early stages. However, the molecular function of seipin remains unclear.
In this thesis, using advanced cell biological techniques in cultured human cells and
zebrafish larvae, we sought to expand the understanding of the function of seipin and
how mutations in seipin lead to human disease.
In the first study, we focused on the seipinopathy-linked seipin mutant, N88S-seipin,
which is known to form cellular aggregates of likely misfolded protein. We found that
overexpression of this variant leads to cellular ER stress, reduced NL storage and
decreased voluntary swimming in zebrafish larvae. Upon increasing NL stores, these
defects were alleviated and the protein was translocated from the ER to regions
flanking LDs. Furthermore, increasing cellular LDs also alleviated ER stress induced
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by tunicamycin, a drug which leads to the accumulation of misfolded proteins in the
ER. We propose that increasing LDs may aid cells in coping with misfolded proteins.
We next focused on deciphering the function of seipin in LD formation and ER-LD
contacts. Endogenously tagged seipin was found to localize stably at ER-LD contact
sites, but a BSCL2-linked mutant failed to do so. Knockout (KO) of seipin led to the
formation of numerous tiny LDs, which failed to grow and recruit protein and lipid
cargo from the ER. Furthermore, whilst all LDs in control cells were connected to the
ER, as assessed by 3D-electron microscopy, seipin KO lead to a subset of LDs
completely detaching from the ER. The remaining LDs of seipin KO cells also showed
morphologically aberrant and dysfunctional ER-LD contacts. As similar defects were
also evident in BSCL2 patient fibroblasts, we propose that seipin is crucial for the
formation of ER-LD contacts and cargo delivery.
Finally, we found that seipin can determine the site where LDs start to form, as
relocalization of seipin to a subdomain of the ER, the nuclear envelope, was sufficient
to relocalize LD biogenesis to that site. Utilizing electron tomography, we found that
seipin-mediated ER-LD contact sites display a uniform neck-like architecture,
suggesting that the seipin oligomer may structurally restrain this site. Seipin was also
required for ER-LD contact maintenance, as acute removal of seipin from ER-LD
contacts lead rapidly to strikingly heterogonous LD growth. Further studies revealed
that this heterogeneity arises via a biophysical ripening process, with NLs partitioning
from smaller to larger LDs via LD-ER contacts. These data suggest seipin-mediated
ER-LD contacts function as a valve facilitating NL flux from the ER to LDs, thus
allowing controlled LD growth.
Overall, this thesis provides insight into the function of the lipodystrophy protein
seipin and the mechanisms of LD formation. Our data suggest that the ER-LD nexus
could be considered as a joint system, with continuous bidirectional trafficking of
cargo occurring via ER-LD contacts mediated by seipin. Future work will be required
to investigate the molecular intricacies of the lipid flux occurring at ER-LD contacts.
A deeper understanding of LD biology will aid in the development of new therapeutics
for a number of pathologies, including seipin-related disorders and common metabolic
disturbances.
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4 REVIEW OF THE LITERATURE
4.1 LIPID DROPLET STRUCTURE AND FUNCTION
LDs are intracellular neutral lipid (NL) storage organelles. They consist of a core of
NLs surrounded by a phospholipid (PL) monolayer, which also harbors LD-associated
proteins. Their main function is to store NLs that can later be used for membrane
constituents and energy production. In addition, they serve as protective organelles
safeguarding cellular homeostasis, by acting as storage depots for reactive fatty acids
and misfolded proteins (Henne et al., 2018). LDs are generated de novo in the
endoplasmic reticulum (ER) and dynamically remodeled in size and numbers in
response to the metabolic needs of the cell.
Though earliest reports of LDs in the literature stem from electron microscopy (EM)
images decades ago (Angermüller and Fahimi, 1982; Kobayashi et al., 1973), LDs
were long thought as passive cytosolic inclusions. The discovery and characterization
of the perilipin family of proteins as LD-specific proteins in the 1990s (Brasaemle et
al., 1997; Greenberg et al., 1991; U et al., 1999) and subsequent advances in live cell
imaging (Martin and Parton, 2006; Targett-Adams et al., 2003) have led to the
appreciation of LDs as dynamic organelles and metabolic hubs (Farese and Walther,
2009; Gao and Goodman, 2015).
Besides playing crucial roles in the regulation of intracellular energy storage and fatty
acid trafficking, LDs are involved in a surprisingly wide array of intracellular
processes, including modulation of the endoplasmic reticulum (ER) stress response,
host-pathogen interactions and protein degradation and storage (Welte, 2015).
Consequently, there is increasing evidence for the importance of LD biology in
various human disease states, including metabolic disorders, non-alcoholic fatty liver
disease, cardiovascular disease and neurodegenerative diseases (Henne et al., 2018;
Krahmer et al., 2013a; Pennetta and Welte, 2018). Furthermore, mutations in proteins
implicated in LD biology lead to rare but devastating congenital disorders such as
lipodystrophy and NL storage disease (Melvin et al., 2019). Thus, understanding the
basic molecular mechanisms of LD assembly could lead to new therapeutic avenues
for these pathologies.
4.1.1 LDs are neutral lipid depots covered by a phospholipid monolayer
Although adipocytes are the professional fat storing cells in many eukaryotic species,
virtually all eukaryotic and at least some prokaryotic cells have the capability to retain
excess NLs and store them in LDs (Pol et al., 2014). The basic structure of LDs is
conserved amongst species, and indeed much of current knowledge of LD biology
stems from research done in model organisms such as Saccharomyces cerevisiae
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(hereafter, yeast) and Drosophila melanogaster (Radulovic et al., 2013). Even bacteria
store NLs in LDs, which participate in their DNA regulation (Congyan et al., 2017).
LDs vary greatly in size, from the 100-nm sized LDs of bacteria and yeast to 10-100-
m sized LDs of mammalian adipocytes (Pol et al., 2014). They are also highly
dynamic in nature, shrinking and growing in size and number in response to the
metabolic status of the cell (Kassan et al., 2013; Rambold et al., 2015). Furthermore,
to enable efficient delivery of LD constituents to different cellular compartments, LDs
are actively trafficked in the cell, with the help of microtubules, the ER and the actin
cytoskeleton (Herms et al., 2015; Li et al., 2012; Pfisterer et al., 2017; Salo et al.,
2016).
The basic structure of LDs consists of a NL core surrounded by a PL coat (Figure 1).
The core is composed of hydrophobic NLs, mainly triacylglycerols (TAG) and
cholesterol esters (CE). The composition of NLs in LDs varies between cell types,
with adipocyte LDs harboring mainly TAG, whilst steroidogenic cell and macrophage
LDs consist primarily of CE (Walther and Farese, 2012). In specialized cells, LDs may
also contain high amounts of other hydrophobic compounds. For example, retinyl
esters are found in high abundance in hepatic stellate cell LDs (Blaner et al., 2009).
The core is devoid of proteins, which cannot be accommodated in this highly
hydrophobic environment. Recent cryo-EM imaging suggest that at least in certain
conditions, the NL core may be organized in various layers due to phase-separation of
TAG and CE molecules (Mahamid et al., 2019).
Figure 1 LDs consist of a core of NLs surrounded by a PL monolayer which harbors LD-associated
proteins. Modified from (Salo and Ikonen, 2020).
In a biophysical sense, LDs can be viewed as oil-in-water emulsions, with NLs giving
rise to a hydrophobic oil phase in the aqueous cytoplasm. To stabilize this emulsion,
a protective surfactant layer is required to reduce the surface tension of the emulsion
and stabilize it. In the context of cellular LDs, the amphiphilic PL coat acts as such a
surfactant, reducing the surface tension of LDs and thus promoting their stability
(Thiam et al., 2013a).  Early EM studies indicated that the PL coat covering the NL
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core of LDs is a single monolayer (Tauchi-Sato et al., 2002). This makes LDs unique,
as they are not surrounded by a PL bilayer like other cellular organelles. In the LD
monolayer, the hydrophobic acyl chains of the PLs face the NLs, whilst the
hydrophilic groups face the aqueous cytoplasm, resulting in an energetically favorable
system (Thiam et al., 2013a).
The PL composition of the LD monolayer affects the properties of the LDs, regulating
LD stability and protein recruitment to LDs (Fei et al., 2011a; Thiam et al., 2013a). In
most cell systems, the LD monolayer is mainly composed of phosphatidylcholine
(PC), phosphatidylethanol (PE) and phosphatidylinositol (PI) as well as other, less-
abundant phospholipids and lyso-phospholipids. The LD monolayer also harbors
diacylglycerol (DAG), although due to its hydrophobicity this lipid may also be stored
in the LD core. The cylindrical PC, with no intrinsic curvature preference, is a more
stabilizing surfactant than PE, which has a small headgroup compared to its acyl
chains and thus exposes more of the hydrophobic phase of the LD to the aqueous
cytoplasm. Decreasing the PC/PE ratio of the PL monolayer would then result in a less
stable emulsion. Indeed, reducing LD PC levels leads to increased LD coalescence,
and this is one mechanism governing LD growth (Haider et al., 2018; Krahmer et al.,
2011). Interestingly, the LD monolayer differs in lipid composition from that of its
mother organelle, the ER, likely due to different activities of PL remodeling enzymes
in these compartments (Tauchi-Sato et al., 2002).
4.1.2 Proteins are embedded in the LD monolayer
While the NL core of LDs is devoid of proteins, the LD monolayer can accommodate
proteins. Due to their high lipid content and the ensuing low density, LDs are relatively
easy to isolate from cells using centrifugation: they tend to float (Goodman, 2018).
Studies utilizing subcellular fractionation techniques followed by mass spectrometry
have yielded information on the proteome of LDs (Beller et al., 2008; Bersuker et al.,
2018; Guo et al., 2008; Krahmer et al., 2013b). Although the LD proteome is diverse
and dependent on the cell type in question and the metabolic status of the cells, a
common set of circa 100-150 high-confidence LD proteins in mammalian cells has
emerged (Olzmann and Carvalho, 2019). In line with the key role of LDs in lipid
metabolism, a many of these proteins are involved in lipogenesis and lipolysis,
including enzymes and their accessory proteins. However, LDs also harbor proteins
involved in a wide spectrum of other processes, including ER-associated degradation
(ERAD), host-pathogen interactions, cytoskeleton regulation and vesicular trafficking
(Goodman, 2018).
4.1.3 Proteins target to LDs from the ER and the cytoplasm
It is currently unclear what mediates protein targeting specifically to LDs. In contrast
to proteins localized to other cellular compartments, such as the ER or mitochondria,
LD proteins lack a specific targeting signal embedded in their sequence (Farese and
Walther, 2009). However, though no universal “zip code” for LD associated proteins
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has been identified, proteins targeting to LDs can roughly be separated into two classes
(class I and class II LD proteins, Figure 2) based on their mode of association with
the LD monolayer (Kory et al., 2016).
Class I proteins are typically found in both the ER and the LD monolayer. They harbor
hydrophobic helical sequences, which typically adopt a “hairpin” topology with both
N- and C-termini facing the cytoplasm. These proteins lack bulky luminal domains,
allowing for both ER bilayer and LD monolayer localization, and the trafficking
between the two organelles could thus occur via diffusion on ER-LD membrane
bridges (Wilfling et al., 2014). Proteins in this category include many lipogenic
enzymes, such as ACSL3, DGAT2 and GPAT4 (Jacquier et al., 2011; Kassan et al.,
2013; Kory et al., 2016; Wilfling et al., 2013). In the absence of LDs, these proteins
typically reside in the ER, but upon LD generation they become highly enriched at
LDs. How this LD enrichment arises is unclear, but may involve selective removal of
ER-associated proteins by proteasomal degradation (Bersuker et al., 2018; Ruggiano
et al., 2016). The hydrophobic hairpin topology alone is not sufficient to ensure LD-
targeting, as many proteins containing such motifs are not recruited to LDs,
implicating other, so far undiscovered regulatory mechanisms (Olzmann and
Carvalho, 2019).
Figure 2 Class I LD proteins (blue) target to LDs via ER-LD contact and often harbor hairpin topology.
Class II LD proteins target to LDs from the cytoplasm via AHs (red), or via protein-protein
interactions with other LD proteins (magenta). Transmembrane proteins with ER luminal
domains (green) cannot target to the LD surface.
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Class II proteins target LDs directly from the cytosol. These include proteins such as
the PC-synthesizing enzyme CCT-alpha and members of the perilipin family (Kory et
al., 2016; Krahmer et al., 2011; Rowe et al., 2016). These typically associate with the
LD monolayer through amphipathic helices (AH), which are characterized by a
segregation of hydrophobic and polar residues to the opposite sides of the helix
(Giménez-Andrés et al., 2018). When bound to the LD monolayer, the hydrophobic
side of the AH is presumed to face the acyl chains of the monolayer, while the
hydrophilic side faces the cytosol, resulting in an energetically favorable situation.
However, many AH containing proteins do not target to LDs and even LD-targeting
AHs differ in length and other biophysical properties, raising the question what
ultimately determines their localization to LDs (Olzmann and Carvalho, 2019).
Finally, some class II proteins associate with LDs through their interactions with other
LD proteins. Examples include the lipase HSL, which associates with LDs through
interaction with perilipin 1 (Sztalryd and Brasaemle, 2017), and Drosophila histones,
which are recruited to LDs by the protein Jabba (Li et al., 2012). Furthermore, a subset
of LD proteins likely interact with LDs through lipid anchors or lipid modifications,
examples including the palmitoylated protein ELMOD2 (Suzuki et al., 2015), the
small GTPase Rab18 (Martin et al., 2005) and the phosphatidic acid (PA) sensing LD-
LD contact site protein CIDEA (Barneda et al., 2015).
4.1.4 LD functions
The main function of LDs is to store energy in the form of energy-dense NLs in times
of excess and release upon demand. This is especially evident in adipocytes, the
professional fat-storing cells, whose entire cytoplasm is often filled up by 1-2 giant
LDs. Upon lipolysis of TAG to free fatty acids (FA) and beta-oxidation of the FAs in
mitochondria, a high amount of energy in the form of ATP can be generated. Besides
energy storage, liberated FAs and glycerol moieties can be converted to PL molecules
to be used for membrane biosynthesis. In addition to these crucial tasks, LDs are also
engaged in numerous other cellular processes (Figure 3).
4.1.4.1 LD are fatty acid buffering organelles
Free FAs are reactive molecules, and as such they are detrimental to cellular functions
and membranes at high concentrations (De Carvalho and Caramujo, 2018). Buffering
of intracellular FA levels by esterification and storage in LDs helps cells to be protect
themselves from such high concentrations and the ensuing lipotoxicity (Listenberger
et al., 2003; Petschnigg et al., 2009). Indeed, numerous studies have demonstrated LDs
to be crucial for lipotoxicity alleviation in various systems, ranging from yeast to
human liver cells (reviewed in (Gluchowski et al., 2017; Kohlwein, 2010)).
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Figure 3 LDs are involved in many cellular processes. Modified from (Salo and Ikonen, 2020).
A recent example of this at a cellular level comes from studies of adipocytes. During
active lipolysis high amounts of FAs are rapidly liberated and, somewhat surprisingly,
high fractions of these free FAs are actually quickly re-esterified into de novo
generated LDs to protect the ER from lipotoxic stress (Chitraju et al., 2017).
Analogously, on the organismal level, neuronal glial cells have been shown to protect
nearby neurons from cellular stress by channeling reactive, easily oxidizable
polyunsaturated FAs (PUFAs) and other FAs to be stored in LDs (Bailey et al., 2015;
Ioannou et al., 2019).
LDs can also be viewed as sensors of cellular nutrient status, which has been most
studied in yeast (Henne et al., 2018). In yeast, during plentiful nutrient availability,
LD abundance somewhat counterintuitively decreases, as cells shuffle lipids to
membrane synthesis to enable active cell proliferation (Markgraf et al., 2014). Upon
switch to nutrient-depleted conditions, LD abundance initially increases, and lipids are
now shuffled to storage in LDs, which can later aid cell survival in the ongoing
nutrient-poor environment (Barbosa et al., 2015; Seo et al., 2017). Similarly, in
mammalian cells, amino acid starvation leads to increased LD generation
concomitantly with the activation of autophagy (Nguyen et al., 2017; Rambold et al.,
2015). The FAs required for the de novo LD generation in these nutrient-poor
conditions likely arise from membrane hydrolysis by the autophagic machinery
(Nguyen et al., 2017; Rambold et al., 2015), and the cells are again utilizing LDs as a
way to robustly buffer intracellular FA levels. Thus, LDs allow cells to cope with
changes in the energy availability of their milieu.
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4.1.4.2 LDs and ER homeostasis
As a separate, but intimately ER-connected membrane compartment (Salo and Ikonen,
2019), LDs also play important roles in ER homeostasis and have been linked to ER
stress pathways (Hapala et al., 2011). Activation of ER stress has been shown to
induce LD formation and LD-deficient cells are more sensitive to perturbations of ER
membrane homeostasis (Chitraju et al., 2017; Fei et al., 2009; Velázquez et al., 2016).
In line with this, ERAD machinery components have often been detected in LD
proteomes (Bersuker and Olzmann, 2017) and LDs constitute an additional
compartment for ER proteostasis (Bersuker et al., 2018; Olzmann et al., 2013). For
some proteins, such as human C18orf32 and yeast Dga1, localization to LDs may help
to prevent their degradation by ERAD, whilst their ER-localized pool is more
susceptible to degradation (Bersuker et al., 2018; Ruggiano et al., 2016). Thus, as a
separate membrane compartment LDs allow an additional layer of control for
membrane protein homeostasis.
It has also been postulated that LDs may serve as sequestration sites for misfolded ER
proteins and/or aid in their translocation from the ER lumen to the cytosol (Hölttä-
Vuori et al., 2013; Ploegh, 2007). However, thus far this has been shown only for a
small subset of ERAD substrates (Hartman et al., 2010; Ohsaki et al., 2008) and recent
studies suggest that LD biogenesis is not a general requirement for ERAD (Olzmann
and Kopito, 2011; To et al., 2017). Overall, however, LDs appear to aid in keeping up
ER homeostasis, and this likely stems from the fact that they provide an additional,
biophysically unique and rapidly malleable membrane compartment, expanding the
cell’s repertoire for homeostasis.
4.1.4.3 LDs are involved in apoptosis and pathogen control
Besides being a storage organelle for NLs needed for energy production, recent studies
have demonstrated LDs to serve as storage site for other lipophilic compounds. The
most studied of these is the role of LDs for retinyl ester storage in hepatic stellate cells
(Blaner et al., 2009), where dynamic remodeling of these stores is involved in stellate
cell activation after liver injury (Molenaar et al., 2017). LDs were also shown to store
acylceramide, a hydrophobic ceramide metabolite, linking LD homeostasis to
apoptosis control (Senkal et al., 2017). A recent study also reported that macrophage
LDs sequester the lipophilic anti-tubercular antibiotic bedaquiline, and thus facilitate
its delivery to Mycobacterium tuberculosis, which consumes cellular LDs for its needs
(Greenwood et al., 2019). Interestingly, increasing LD abundance improved the
efficacy of the drug in clearing out Mycobacterium infection, suggesting avenues for
improving therapeutics in the future.
LD biology has been linked to numerous pathogens, both bacteria and viruses (Melo
and Dvorak, 2012). Typically, infection with these pathogens, ranging from viruses
(e.g. hepatitis C virus), to bacteria (e.g. E. Coli and Mycobacterium tuberculosis) and
parasites (e.g. Toxoplasma gondii) lead to an increase in LD formation. The molecular
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mechanisms leading to this phenomenon are still under investigation, but LDs likely
play a dual role: they are both part of the host defense mechanism and advantageously
used by the invading pathogen (Pereira Dutra et al., 2019). Examples of the former
include the role of LD-associated histones helping developing Drosophila embryos in
fighting off bacterial infection (Anand et al., 2012). On the other hand, especially
intracellular bacteria and parasites appear to use de novo generated LDs as a nutrient
source (Barisch and Soldati, 2017). Finally, viruses also use the LD, and nearby LD-
associated ER membranes as platforms for virus assembly and replication (Laufman
et al., 2019; Lee et al., 2019; Miyanari et al., 2007).
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4.2 LIFE CYCLE OF LDS
LDs are dynamic organelles, constantly changing in size and number in response to
the metabolic status of the cell (Figure 4). LD life cycle can be segregated into a series
of discrete steps, starting with initial biogenesis in the ER, followed by further growth
and finally, breakdown (Thiam and Beller, 2017). In cellular studies, to harmonize
these processes and enable quantitative study, cells are often treated with high
concentrations of extracellular lipids (such as oleic acid, OA) to facilitate LD
biogenesis and, conversely, switched to nutrient-poor conditions to facilitate LD
breakdown. However, even in these conditions individual LDs within cells are
variable in size and can be thought of as being in a different stage of their life cycle,
and this is likely even more pronounced in vivo.
Figure 4 Life cycle of LDs. Modified from (Salo and Ikonen, 2020).
4.2.1 Lipid biosynthesis pathways
LD biology is closely linked to the intertwined NL and PL synthesis pathways
(summarized in Figure 5) (Pol et al., 2014). These biochemical pathways are regulated
at each step by numerous factors, including substrate availability, enzymatic activities
and specificities as well as subcellular localization of the enzymes, leading to a
complex regulatory network. This matter is further complicated by the fact that
typically, a number of enzymes can catalyze each enzymatic step, albeit at different
efficiencies. As most of our knowledge on specific enzymes stems from in vitro work,
it is a future challenge to characterize the reaction rates of these pathways in vivo
(Takeuchi and Reue, 2009).
This aforementioned complexity is well exemplified in the pathway for de novo TAG
generation (Figure 6). Here, enzymes of GPAT, AGPAT, PAP/lipin and DGAT
families work in concert to esterify glycerol and activated FAs to finally form TAG.
Many of the intermediates, such as DAG and PA can instead be reshuffled to
alternative metabolic fates, including PL synthesis, or utilized as secondary messenger
molecules (Vance, 2015). For each enzymatic step, 2-10 putative enzymes exist in
mammalian cells, although there likely exists a high degree of cell-type and
subcellular localization dependent variation (Takeuchi and Reue, 2009). Except for
the primarily cytosolic lipins, these enzymes are mostly membrane-bound proteins,
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residing in the ER, mitochondrial membranes and, in some cases, on the LD
monolayer (Wang et al., 2017).
Figure 5 An overview of NL and PL pathways involved in LD biology in mammalian cells, including
de novo NL synthesis (orange), FA activation (blue), Kennedy pathway of PC biosynthesis
(red) and the Lands cycle of PL remodeling (green). Enzymatic steps are in italics, multiple
enzymes may exist for each step. Asterisk indicates steps only active in specialized cell types,
such as adipocytes or liver cells. Although not indicated, many of the steps shown here require
or release activated FAs. PEMT, phosphatidylethanolamine-N-methyltransferase (this
pathway is mostly active in liver); PSD, phosphatidylserine decarboxylase; PSS,
phosphatidylserine synthase; PLA, phospholipase A; PLD, phospholipase D; GDH, glycerol-
3-phosphate dehydrogenase; GK, glycerol kinase (mostly active in liver and kidney); DGK
diacylglycerol kinase; SE, sterol esterase; CDP-choline, cytidine diphosphatase choline; P-
choline, choline phosphatase; LPC lysophosphatidylcholine; FC, unesterified cholesterol,
MAG (monoacylglycerol); DHAP, dihydroxyacetone phosphate; SOAT, sterol-o-
acyltransferase CCT-alpha, CTP:phosphocholine cytidylyltransferase alpha. Adapted from
(Pol et al., 2014).
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Many PL and NL generating reactions require activated FAs in the form acyl-
coenzyme A (acyl-CoA) as substrates. FA activation occurs via an ATP-dependent,
two-step reaction catalyzed by ACSL enzymes. Remarkably, at least 11 ACSL
enzymes have been documented in mammalian cells (Takeuchi and Reue, 2009), but
whilst these all catalyze the same reaction, they differ in their subcellular localization
and affinities for FAs with different acyl chain lengths and saturation. The
compartmentalization of ACSL as well as other lipid biosynthesis enzymes is likely
crucial for efficient cellular metabolism but is still incompletely understood (Ellis et
al., 2010; Young et al., 2018). Of the ACSL enzymes, the ER and LD localized ACSL3
appears to be especially important in NL synthesis for LD generation (Kassan et al.,
2013; Poppelreuther et al., 2018).
Figure 6 Schematic of de novo TAG generation
pathway. Acyl-CoA synthetase (ACSL) enzymes
catalyze Acyl-CoA formation, a substrate for many
subsequent steps. Glycerol-3-phosphate (G3P) is
converted to lysophosphatidic acid (LPA) via the
activity of 1-glycerol-3-acyltransferase (GPAT)
enzymes. LPA is converted to phosphatidic acid
(PA) via the activity of 1-acylglycerol-3-
phosphate-acyltransferase (AGPAT) enzymes. PA
is dephosphorylated to DAG by phosphatidic acid
phosphatase (PAP/lipin) enzymes. DAG is
esterified to TAG by diacylglycerol acyltransferase
(DGAT) enzymes. Numbers in parentheses
indicate the number of putative isoforms in
mammalian cells (Takeuchi and Reue, 2009)
4.2.2 LD biogenesis
De novo LD biogenesis begins in the ER, which also harbors the terminal enzymes of
both TAG and CE synthesis, namely DGAT1, DGAT2, SOAT-1 and SOAT-2 (Chang
et al., 2009; Yen et al., 2008). With the exception of DGAT2, these are integral
multispanning ER transmembrane (TM) proteins, which thus cannot be
accommodated on the LD monolayer (Walther et al., 2017). DGAT2, on the other
hand, harbors a hairpin-like motif instead of a true TM domain, allowing for dual
localization to the ER and LDs (Kuerschner et al., 2008; McFie et al., 2018; Wilfling
et al., 2013). Besides NL synthesizing enzymes, various accessory proteins, such as
seipin, FITM2, Rab18 and perilipins, have been shown to play roles in the early steps
of LD biogenesis (Walther et al., 2017).
Initial LD biogenesis is thought to occur within the bilayer of the ER (Pol et al., 2014).
Newly synthesized NLs are deposited within the leaflets of ER bilayer and are initially
likely freely diffusing. To date, there is no direct evidence indicating that this early
NL synthesis would occur on any specific ER subdomains, as in the absence of pre-
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existing LDs, the TAG synthesizing machinery appears to be dispersed all around the
ER, although detailed studies are lacking (Jacquier et al., 2011; Stone et al., 2009).
Nevertheless, a bilayer can only accommodate minute concentrations ( 3 mol%
according to in vitro studies (Hamilton et al., 1983)) of TAG without biophysical
forces driving the oil phase to nucleate, i.e. form a nm-sized lens (Walther et al., 2017).
These lens-like aggregations have been predicted by molecular dynamic simulations
(Khandelia et al., 2010; Pezeshkian et al., 2017) and observed in yeast by EM
(Choudhary et al., 2015). Subsequent growth of such lens like-structures is postulated
to lead to the deformation of the ER bilayer, resulting in a budding out of a small
nascent LD towards the cytoplasmic side (Figure 7). After further growth, these
structures become clearly identifiable LDs that may subsequently detach from the ER
(Olzmann and Carvalho, 2019; Wilfling et al., 2013), although recent studies indicate
that this is rarely, if ever, the case in normal cells (discussed in detail below and
reviewed in (Salo and Ikonen, 2019)).
Figure 7 Early steps of LD biogenesis. Modified from (Salo and Ikonen, 2020).
There are still a number of unanswered questions regarding this model of LD
biogenesis. Due to their small size and possible instability, nascent LD lenses have
been difficult to identify and study in cells or in vitro. Though 40-60 nm sized lens-
like structures were detected in yeast (Choudhary et al., 2015), we detected budded
out LDs in the size range of 30 nm in mammalian cells (Salo et al., 2019), whilst
theoretical studies suggested a budding size of circa 12 nm (Zanghellini et al., 2010).
Thus, the size limit of smallest forming LDs is yet unknown and may vary between
cell types.
The forces leading to the budding of LDs are also unclear, and especially intriguing is
the observation that LDs almost exclusively bud out to the cytoplasmic side of the ER.
These processes likely involve both facilitating protein machinery and a favorable
local lipid environment (Choudhary et al., 2018; Jackson, 2019; Ben M’barek et al.,
2017). Thus, LD biogenesis is thought to occur in specialized, but yet poorly
characterized ER subdomains where these factors come together to collaborate in LD
budding and nascent LD growth (Pol et al., 2014). Of note, separating these two
seemingly distinct steps experimentally is difficult, as the nascent LDs are well below
conventional microscopy resolution and biochemical detection limits. Thus,
deductions on how protein and lipid composition effects early LD formation steps are
often made based on observed LD alterations at a later time point, i.e. how LDs appear
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after they have already formed. To date, no single protein has been found
indispensable for LD formation (Guo et al., 2008). Indeed, theoretical work suggests
that with rising NL concentrations, LD-like structures will eventually bud out of the
ER even in the absence of any dedicated protein machinery, due to the biophysical
properties of NLs in an aqueous environment (Deslandes et al., 2017). However,
within cells, a collaboration of proteins such as seipin, FITM2, ACSL3 and perilipins
controls nascent LD formation (Chen and Goodman, 2017).
Seipin, discussed in detail below, may regulate the local PL composition and/or
structurally control nascent ER-LD contacts to enable nascent LD growth (Salo et al.,
2019). FITM2, an ER TM protein which was shown to be capable of directly
interacting with TAG, may shuffle TAG to the nascent LD and regulate local DAG
levels to enable LD budding (Choudhary et al., 2018; Gross et al., 2011). FITM2 was
also proposed to harbor PL remodeling enzymatic capabilities, leading to the
suggestion that it may modulate the surface tension of the luminal leaflet of the ER at
LD formation sites and thus facilitate directional budding of LDs to the cytoplasmic
side (Becuwe et al., 2018; Hayes et al., 2018). ACSL3, an acyltransferase shown to
mark nascent LD formation sites (Kassan et al., 2013), likely plays a role by increasing
the local concentration of activated FAs, necessary for PL and TAG synthesis
(Poppelreuther et al., 2018). Cytoplasmic perilipin proteins, especially perilipin-3,
may sense the increased local concentration of NLs or DAG at the ER. By
accumulating at these sites perilipins may aid in nascent LD stabilization and, possibly
through protein crowding effects, facilitate bilayer deformation to enable LD budding
(Bulankina et al., 2009; Gao et al., 2017b; Skinner et al., 2009; Thiam and Beller,
2017). Finally, multiple ER-shaping proteins have been shown to affect LD assembly
(Falk et al., 2014; Klemm et al., 2013; Papadopoulos et al., 2015; Renvoisé et al.,
2016). A reason for this may be modulation of the local ER surface tension, leading
to alterations in LD formation and/or growth (Deslandes et al., 2017; Wang et al.,
2018b).
Indeed, multiple lines of evidence suggest that local ER membrane lipid composition
at LD forming sites plays an important role in regulating LD emergence, and the role
of proteins may be to primarily control this parameter. In a recent study, the intrinsic
curvature of PLs was found to regulate ER budding: negatively curved lipids (e.g.
DAG), facilitated LD embedding in the ER whilst positively curved lipids (e.g.
lysolipids) facilitated budding out of the ER (Choudhary et al., 2018). Besides
inducing curvature, various PLs also differentially modulate the surface tension of the
ER bilayer, and this was shown to effect the size of emerging LDs in a study primarily
utilizing model membranes and artificial LDs (Ben M’barek et al., 2017).
Asymmetrical distribution of PLs between the ER bilayer leaflets and the
consequential difference in surface tension may also aid in ensuring LD budding
towards the cytoplasmic side of the membrane (Chorlay and Thiam, 2018). This could
arise via certain PLs showing a preference for the luminal vs cytoplasmic side of the
bilayer, as has been shown previously for phosphatidylserine (PS) at the plasma
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membrane and more recently also at the ER (Tsuji et al., 2019). Indeed, membrane
asymmetry, resulting in different surface tensions, achieved either via an excess of
PLs or proteins on one side vs the other has been proposed to impose directionality on
LD emergence from the ER (Chorlay et al., 2019). Overall, local lipid composition
likely plays a key role in nascent LD formation and budding and studies utilizing
fluorescent lipid sensing proteins have implicated local increases of PA and DAG at
LD forming sites in the yeast ER (Choudhary et al., 2018; Wolinski et al., 2015).
However, direct proof of LD-forming ER subdomains having a different lipid
composition than that of the bulk ER is lacking and would require advances in
subcellular lipidomic techniques.
4.2.3 LD growth
After formation, a LD can grow in size via acquisition of more NLs to its core and
concomitant expansion of the LD monolayer. This occurs via at least three different
pathways acting in parallel: via lipid deposition from the ER to LDs via ER-LD
contacts; via localized lipid synthesis on the LD monolayer; and via transfer of lipid
constituents between neighboring LDs through fusion or ripening (Barneda and
Christian, 2017) (Figure 8). In principle, more lipids could also be delivered to LDs
via vesicular transport, but thus far direct evidence for this is lacking (Penno et al.,
2013).
Figure 8 Modes of LD growth. Modified from (Salo and Ikonen, 2020).
4.2.3.1 LD growth via ER-LD contacts
The notion that LD expansion may be driven by lipid transport via ER-LD contacts is
not surprising considering that most of the machinery for NL synthesis is ER-resident.
Furthermore, whilst the rate-limiting enzyme for the major PL, PC, synthesis (CTT-
alpha) can localize to the LD monolayer in some cell types (Krahmer et al., 2011),
although not in others (Aitchison et al., 2015; Haider et al., 2018), the terminal
enzymatic steps of PC synthesis occur solely at the ER or Golgi (Henneberry et al.,
2002). Thus, a likely source for additional material for LD expansion is the ER, with
newly synthesized lipids transported to the LD via ER-LD contacts. Indeed, although
traditionally it was assumed that after their formation, most LDs would detach from
ER membranes to become isolated cytoplasmic organelles, recent studies have shown
that most – if not all – LDs appear to stay in touch with their mother organelle
throughout their lifetime (Salo and Ikonen, 2019).
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A subset of ER-LD contact sites are postulated to be unique in terms of their topology,
with direct membrane continuity between the ER bilayer and LD monolayer, with the
ER-LD contact site being a membranous bridge (Salo and Ikonen, 2019). This is in
contrast to traditional membrane contact sites, where tethering proteins bring
organelles within nm distances of each other, but the individual membranes remain
separated (Schuldiner and Bohnert, 2017). This topology would ensure rapid diffusion
of lipid constituents between the two cellular compartments. Hints of such
membranous bridges have been seen in EM images of ER and LDs (Kassan et al.,
2013; Romanauska and Köhler, 2018; Salo et al., 2019; Wilfling et al., 2013). This
aspect was thoroughly investigated in a landmark yeast study, where FRAP
experiments demonstrated movement of proteins from the ER to the LD surface in a
temperature and energy independent manner, suggesting direct connectivity (Jacquier
et al., 2011). Since then, FRAP has demonstrated rapid exchange of both lipid and
protein cargo between the ER and LDs in multiple cell types (Kimura et al., 2018;
Salo et al., 2016; Wilfling et al., 2013). The lipodystrophy protein seipin has been
implicated in the formation and maintenance of such bridges (Grippa et al., 2015;
Romanauska and Köhler, 2018; Salo et al., 2019).
Figure 9 Examples of ER-LD contacts from light microscopy (a), 3D-EM (b) and electron tomography
images. Note both discrete and extended ER-LD contacts in c. Scale bars: 1 μm and 5 μm (a),
1 μm (b), 200 nm (c). Reproduced from (Salo and Ikonen, 2019).
In addition to membranous bridges, proteinaceous tethers between the ER and LDs
also exist, and structures reminiscent of these have been detected in EM images (Salo
et al., 2019; Wang et al., 2016a). Candidates for forming these tethers include ER and
LD resident proteins coming together to form a bridging complex. These include a
complex of FATP1 (ER) and DGAT2 (LD) (Xu et al., 2012), Rab18 (LD) together
with members of the NRZ complex and associated SNARE proteins (ER) (Xu et al.,
2018), and Orp2 (LD) and VAPA (ER) (Weber-Boyvat et al., 2015). Recently, Snx14
was also shown to be capable of tethering LDs to the ER, by binding to both organelles
simultaneously (Datta et al., 2019) and a similar topological arrangement has been
proposed for DGAT2 (McFie et al., 2018). Interestingly, in all these cases, tethering
of the two organelles was proposed to facilitate LD growth, although the exact
mechanisms underlying this are unknown. Finally, LDs are also frequently detected
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to touch the ER membrane for extended lengths, in an egg-in-a-cup conformation
(Jacquier et al., 2011; Mishra et al., 2016; Robenek et al., 2006), but the significance
for this kind of conformation for LD growth is unknown. Examples of ER-LD contacts
are shown in Figure 9.
4.2.3.2 LD growth via lipid synthesis on the LD
Besides lipid deposition from the ER via ER-LD contacts, TAG synthesis can also
occur at the LD monolayer, independent of the ER. In an landmark study, it was
demonstrated that at least one member of all the enzymes required for de novo TAG
generation – such as ACSL3, GPAT3, AGPAT2, DGAT2 - can relocate from the ER
to LDs, where they facilitate LD expansion by catalyzing TAG synthesis (Wilfling et
al., 2013). Interestingly, this DGAT2-dependent pathway typically targets only a
subset of cellular LDs, termed “expanding LDs” which consequently grow larger than
other LDs in the same cell (Walther et al., 2017).
It is presently unclear how this LD diversity is achieved, i.e. what precludes from all
LDs acquiring the TAG synthesizing enzymes, but the Arf1/COPI machinery was
shown to be necessary for GPAT3 localization to LDs (Wilfling et al., 2014). This is
thought to arise via COPI-mediated budding of small nano-LDs from the LDs,
resulting in an increase in LD surface tension (Thiam et al., 2013b; Wilfling et al.,
2014). Alteration of the LD surface tension could then allow these enzymes to diffuse
from the ER to LDs via ER-LD bridges as described above. In the original study,
COPI-mediated alteration of the LD surface tension was suggested to result in de novo
ER-LD bridge formation (Wilfling et al., 2014), but it appears plausible that such
bridges may exist independent of COPI activity, and the trafficking of proteins via
these bridges is controlled by COPI machinery. Seipin has also been implicated in this
process, as seipin perturbation in Drosophila cells leads to an increase of the
expanding LD population, with earlier and increased targeting of the TAG synthesis
machinery to a subset of LDs (Wang et al., 2016a). Together with data proposing that
seipin acts as a diffusion barrier controlling LD surface tension (Grippa et al., 2015),
these findings suggest that the expanding LDs likely differ in their monolayer
properties from those of other LDs.
Of note, as discussed above, currently there is no evidence for de novo
phosphatidylcholine synthesis on the LD monolayer. The last step of PC synthesis, the
conversion of CDP-choline to PC, is catalyzed by choline phosphotransferase, CPT,
an ER resident enzyme (Henneberry et al., 2002). Furthermore, isolated LDs lack this
enzymatic activity (Moessinger et al., 2011). The substrate for this enzymatic step,
CDP-choline, can be generated at LDs in at least some cell types, by the activity of
CCT-alpha, and LD growth has been shown to facilitate the relocation and activation
of this enzyme at LDs (Aitchison et al., 2015; Krahmer et al., 2011). Thus, during LD
expansion, local activation of CCT-alpha may lead to local increases in CDP-choline
levels, which could rapidly be transferred to the ER, converted to PC and then
transferred back to the LD. The delivery of these compounds could arise via diffusion
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through ER-LD contacts or via transfer by lipid transfer proteins, and allow for LD
monolayer expansion (Penno et al., 2013).
Interestingly, VPS13, a recently described lipid transfer protein capable of PC transfer
in vitro, was shown to localize to multiple ER contact sites, including those between
the ER and LDs (Kumar et al., 2018). Furthermore, PC-remodeling
lysophosphatidylcholine acyltransferase (LPCAT) enzymes have been localized to
LDs and shown to be important for LD growth (Moessinger et al., 2011, 2014). As
their substrates (lyso-PC and activated FAs) are relatively water soluble molecules,
they might be transferred to LDs independent of ER-LD contacts, and PC could thus
be generated at the LD directly (Penno et al., 2013).
Overall, it is clear that LDs can grow both via ER-derived NL transfer and LD-
autonomously via generation of TAG at the LDs. However, their relative contribution
to LD growth is presently unclear. Indeed, this is likely dependent on both the cell
types in question and the metabolic status of the cells. A major contributing factor may
be the relative activities of DGAT1 and DGAT2, the former being a permanently ER-
localized protein whilst the latter can be localized to both ER and LDs (Barneda and
Christian, 2017; Olzmann and Carvalho, 2019; Wilfling et al., 2013). Of note, CE
synthesis is permanently restricted to the ER (Chang et al., 2009), implicating ER-to-
LD lipid transport as the main mode of expansion for exclusive CE containing LDs.
4.2.3.3 LD growth via lipid transfer between LDs
LDs can also grow by lipid transport from one LD to another, typically between
adjacent LDs. This can be achieved via two biophysically distinct mechanisms with
different time scales: LD-LD fusion, which is a rapid merging or coalescence of
droplets (occurring within seconds); and Ostwald ripening, a molecular diffusion
process by which smaller droplets continuously leak material to bigger ones through
a connecting phase (occurring over minutes-hours) (Thiam and Forêt, 2016; Thiam et
al., 2013a). Somewhat confusingly, both processes are often referred to simply as
“fusion” in the literature. As these processes are facilitated by LD-LD contacts and
proximity, they can be modulated by factors influencing LD-LD clustering, such as
microtubule and actin cytoskeleton networks (Boström et al., 2007; Pfisterer et al.,
2017) and proteins inducing LD clustering (Jambunathan et al., 2011; Lohmann et al.,
2013). Upon LD coalescence, the total volume of fusing LDs remains the same, whilst
the surface area decreases. In line with this, cells deficient in PL synthesis often
contain larger LDs via an increased rate of LD-LD fusion (Guo et al., 2008; Krahmer
et al., 2011).
Rapid fusion of two nearby LDs to become a single LD appears to be relatively rare
in intact cells, as cells often contain clusters of relatively similar-sized LDs, stable for
long periods of time. This is due to the surfactant properties of the LD monolayer,
which efficiently protects the LDs from coalescence (Thiam et al., 2013a). However,
rapid merging of adjacent LDs within seconds has been observed in vivo (for example,
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in (Pfisterer et al., 2017)) and can be induced by addition of surface-reactive molecules
that disrupt the LD monolayer and thus induce coalescence (Murphy et al., 2010).
Slower LD-LD fusion process, termed ripening, has more frequently been observed in
cells, and is a major contributor to the growth of LDs during adipogenic differentiation
(Jüngst et al., 2013; Paar et al., 2012). In this process, the larger LD acquires lipids
from the smaller LD due to a difference in the internal pressure of the LDs, which is
dependent on the size difference of the LDs (Thiam et al., 2013a). This process is
facilitated by Fsp27, a protein mutated in congenital lipodystrophy (Rubio-Cabezas et
al., 2009). Fsp27 is enriched at LD-LD contact sites, where it facilitates the growth of
the larger LD at the expense of the smaller LD, possibly by increasing the local PL
barrier permeability, allowing NL transfer (Barneda et al., 2015; Gao et al., 2017a;
Gong et al., 2011). Our studies have recently indicated that ripening can also occur
between nearby LDs via the connecting ER bilayer, and this process is controlled  by
seipin, probably through modulation of ER-LD contact site functionality (discussed in
detail in Results and Discussion) (Salo et al., 2019).
4.2.4 Breakdown of LDs
The canonical function of LDs is energy storage. Upon times of cellular demand, the
NLs of the LD core can be broken down to release free FAs for energy production and
membrane synthesis. This is achieved via lipolytic enzymes, hydrolyzing NLs at the
LD monolayer, or via engulfment of LD constituents into degradative vesicles in a
specialized form of selective autophagy, termed lipophagy (Zechner et al., 2017)
(Figure 10). Both processes result in the breakdown of the ester bonds in NLs by
enzymatic hydrolysis, resulting in the liberation of free FAs.
Figure 10 Modes of LD breakdown. Modified from (Salo and Ikonen, 2020).
The main mammalian lipases acting on TAG are ATGL (adipose tissue triglyceride
lipase), HSL (hormone sensitive lipase) and MGL (monoacylglycerol lipase)
(Kraemer and Shen, 2002; Schweiger et al., 2006; Zimmermann et al., 2004). ATGL
has higher in vitro activity on TAG, whilst HSL is more efficient at hydrolyzing the
resulting DAG, but both enzymes co-operate in a cell-type specific manner (Zechner
et al., 2009). The product of DAG hydrolysis, MAG, is further broken down by MGL.
ATGL and HSL act at the LD monolayer, whilst MGL is cytoplasmic, and their
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activities are regulated by various cellular cues, including perilipin proteins (Sztalryd
and Brasaemle, 2017; Zechner et al., 2017).
For example, in adipocytes during basal conditions, perilipin-1 is enriched at the LD
surface, binding CGI-58, a potent cofactor of ATGL (Lass et al., 2006; Subramanian
et al., 2004; Yamaguchi et al., 2004). Upon increased demands for energy,
catecholamines activate protein kinase A (PKA), which phosphorylates perilipin-1,
resulting in release of CGI-58 to activate ATGL (Sztalryd and Brasaemle, 2017).
Concomitantly, phosphorylated perilipin-1 also more efficiently recruits HSL to the
surface of LDs (Miyoshi et al., 2006; Sztalryd et al., 2003). Acting in concert, these
lipases then catalyze efficient TAG degradation into free FAs, to be used for
membrane synthesis or ATP production in mitochondria through beta-oxidation
pathways.
The fate of the LD-liberated FAs may further be regulated by spatiotemporal control
of LD-mitochondria proximity. Indeed, during energy depleted conditions, LDs are
recruited to the vicinity of mitochondria (Herms et al., 2015; Rambold et al., 2015;
Valm et al., 2017), likely leading to more efficient usage of liberated free FAs for
energy production. This relocalisation of LDs is regulated by transport along
tyrosinated microtubules in a process regulated by the cellular energy sensor, AMPK
(Herms et al., 2015). Mitochondria-LD contacts are also facilitated by perilipin-5,
which has been proposed to act as a tether between these two organelles (Kimmel and
Sztalryd, 2014; Wang et al., 2011).
Whilst lipases on the LD monolayer brake down NLs one molecule at a time, LDs can
also be degraded in larger portions via lipophagy (Singh et al., 2009). In this process,
entire small LDs or portions of larger LDs are engulfed into autophagosomes, which
subsequentially fuse with lysosomes and NLs are hydrolyzed by the lysosomal
enzyme LAL (lysosomal acid lipase) (Zechner et al., 2017). Molecular cues marking
LDs for degradation by autophagosomes are currently under investigation, but may
involve direct, transient interaction of lysosomes with LDs in a process regulated by
Rab7 (Schroeder et al., 2015). Whilst the molecular details and regulatory loops
involved in lipophagy are only beginning to be unraveled, it is currently accepted that
both lipolysis at the LD surface and lipophagy are required for maximal LD
breakdown efficiency in most cell types (Schulze et al., 2017). Interestingly, recent
studies in hepatocytes suggest LD size may determine which mode of breakdown
dominates, with larger LDs being more susceptible to breakdown by lipases and
smaller LDs to lipophagy (Schott et al., 2019).
Overall, a major outstanding question in understanding LD size changes in cells is
deciphering how cells can efficiently couple LD core NL changes with the expansion
and shrinkage of the LD monolayer. Seipin has been implicated in this process (Grippa
et al., 2015; Salo et al., 2019; Wang et al., 2016a), but its precise role still remains
unclear.
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4.3 SEIPIN
Seipin is an oligomeric ER TM protein, implicated in LD formation and adipogenesis.
Seipin was first identified as the gene defective in BSCL2, a severe form of congenital
lipodystrophy (Magré et al., 2001), whilst subsequent studies have documented other
seipin mutations giving rise to hereditary spastic paraplegias (Windpassinger et al.,
2004) and a severe form of encephalopathy with fatal outcomes at a young age
(Guillén-Navarro et al., 2013). Seipin is required for adipogenesis, and studies in a
wide variety of model organisms have implicated an evolutionary conserved role for
seipin in LD assembly, with a typical loss of function/knockout (KO) phenotype of
supersized and tiny LDs (Cartwright and Goodman, 2012; Dollet et al., 2014;
Sarmento et al., 2018). However, despite considerable effort, including recent cryo-
EM structural studies, the molecular mechanism of seipin function(s) remains unclear
(Gao et al., 2019; Henne et al., 2020).
4.3.1 Seipin structure and conservation
Seipin is an integral ER membrane protein, with two TM domains, a luminal loop and
amino- and carboxyterminal cytoplasmic ends (Lundin et al., 2006; Windpassinger et
al., 2004) (Figure 11). In humans, BSCL2, the gene coding seipin, is ubiquitously
expressed, with highest expression levels in the brain and testes (Magré et al., 2001;
Windpassinger et al., 2004). BSCL2 gives rise to three transcripts, isoform 1 (398
amino acids (aa)), isoform 2 (287 aa) and isoform 3 (462 aa) (Sarmento et al., 2018).
Isoforms 1 and 3 contain the intraluminal loop and both TM domains, but isoform 3
has an extended N-terminal sequence compared to isoform 1. Isoform 2 differs from
the others in its C-terminal sequence and may lack the second TM completely. Its
expression appears to be limited to the central nervous system and to date there is no
evidence at the protein level of its existence (Magré et al., 2001; Sánchez-Iglesias et
al., 2016; Windpassinger et al., 2004). Indeed, the functional relevance of these
various isoforms is unclear. Isoform 1 is the most commonly studied in the literature
and subsequent aa numberings refer to that.
Figure 11Schematic of seipin
isoform 1. Select missense and
truncation mutations implicated
in BSCL2 (green) and
seipinopathy (magenta) are
shown. X denotes introduction
of premature stop codon. Seipin
is N-glycosylated at N88-S90.
Adapted from (Wee et al., 2014).
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Two genome-wide screens conducted in S. cerevisiae found seipin to be essential for
proper LD morphology, with a phenotype of supersized and tiny LDs in its absence
(Fei et al., 2008; Szymanski et al., 2007). In accordance with a lipodystrophic
phenotype in humans, seipin was found to be essential for proper adipogenesis in mice
(Chen et al., 2009; Cui et al., 2011; Payne et al., 2008), Drosophila (Tian et al., 2011),
rat (Ebihara et al., 2015) and human cells (Mori et al., 2016; Victoria et al., 2010).
Furthermore, studies have revealed a crucial role for seipin in LD morphology in
multiple model organisms, including various non-adipogenic human cell lines (Boutet
et al., 2009; Salo et al., 2016; Wang et al., 2016a), A. thaliana (Cai et al., 2015), C.
elegans (Cao et al., 2019), D. amoebae (Jessica M. Kornke, 2017) and R. toruloides
(Coradetti et al., 2018).
The intraluminal region and the two flanking TM segments are the most conserved
domains of seipin between different species (Fei et al., 2008; Sarmento et al., 2018;
Szymanski et al., 2007). This region has thus been denoted as the conserved core
sequence, hypothesized to relate to seipin’s core function in LD formation, while the
extended cytoplasmic regions (found in multicellular organisms) may relate to a more
complex role for seipin in specialized fat-storing cells, such as adipocytes (Yang et
al., 2013). This hypothesis stems from the fact that the LD phenotype of yeast seipin
KO cells can be rescued by human seipin, even a truncated form lacking the
cytoplasmic C-terminus (Fei et al., 2008), whilst rescue of defective adipogenesis in
seipin depleted cells requires the full-length protein (Yang et al., 2013). Furthermore,
some BSCL2-causing truncation mutants only lack small portions of the C-terminus,
implying significance of this domain for fat storage (Talukder et al., 2015).
In yeast, seipin interacts with ldb16, an ER TM protein with no known mammalian
homologues (Grippa et al., 2015; Wang et al., 2014). Depletion of either yeast seipin,
ldb16 or both result in largely indistinguishable phenotypes, which can be rescued by
expression of human seipin, including a variant only containing the core sequence
(Grippa et al., 2015; Wang et al., 2014). In line with this, also LD biogenesis defects
in Drosophila cells could be rescued with constructs lacking both N- and C-termini
(Wang et al., 2016a). Overall, these data suggest that the (currently unresolved)
function of seipin in LD-formation is accomplished by its core sequence, and the
cytoplasmic termini may have additional roles, putatively important for adipogenesis.
This model is challenged, however, by the intriguing finding that fat storage defects
in Drosophila fat body can be rescued by Drosophila seipin lacking the C-terminus,
whilst rescue of ectopic lipid storage in non-adipose tissues in this model requires the
full-length protein (Tian et al., 2011).
4.3.1.1 The structure of the seipin oligomer
Seipin forms homo-oligomers in the ER. Early reports of purified yeast seipin,
analyzed via negative staining EM, suggested a toroid conformation of circa 9 subunits
(Binns et al., 2010), whilst atomic force microscopy (AFM) of immuno-purified
human seipin suggested a complex of 12 subunits in a circular conformation (Sim et
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al., 2013). In line with this, endogenously fluorescently tagged Drosophila and human
seipin appear as discrete, mobile foci in the ER (Salo et al., 2019, 2016; Wang et al.,
2016a). Finally, recent cryo-EM structures of the luminal region of Drosophila and
human seipin reported oligomers of 12 and 11 subunits, respectively (Sui et al., 2018;
Yan et al., 2018), and a preliminary report suggests yeast seipin to be composed of 9
subunits (Henne et al., 2020). Oligomerization is instrumental for seipin function, and
several BSCL2-causing point mutants appear to impair seipin oligomerization and
function. The best studied example is the BSCL2-causing point mutant A212P (Magré
et al., 2001), which has been shown to exist as smaller oligomers than WT seipin, as
assessed by EM and AFM of purified preparations (Binns et al., 2010; Sim et al., 2013)
and super resolution microscopy of intact cells (Salo et al., 2016). Finally, a mutant
designed based on the seipin cryo-EM structure to hinder oligomerization, failed to
complement seipin function in cells (Yan et al., 2018). However, the exact number of
subunits in the oligomer appears not to be critical for seipin function, as human seipin
(11 subunits) has been shown to rescue both yeast (9) and Drosophila (12) seipin-
depleted phenotypes in LD formation (Henne et al., 2020; Wang et al., 2014, 2016a).
Figure 12 Seipin oligomer structure. The TM regions were modelled into the cryo-EM structure of the
luminal domains of human seipin (Yan et al., 2018) using PyMol software. Image credit:
Xavier Prasanna.
Besides providing insight into the oligomerization status of seipin, the cryo-EM
structures of human and Drosophila seipin revealed several notable structural features
(Figure 12). Interestingly, neither study could resolve the structures of the
cytoplasmic regions of seipin, which likely reflects structural flexibility in these
regions (Sui et al., 2018; Yan et al., 2018). The luminal structures of both species
showed a ring-like structure of circa 15 nm in diameter, consisting of 11-12 seipin
monomers closely intertwined. Each monomer harbors two notable features: several
hydrophobic helices in very close proximity to the bilayer membrane, and two beta
sheets, each consisting of four beta-strands, with an overall fold reminiscent of lipid
binding domains of proteins such as NPC2 (Sui et al., 2018; Yan et al., 2018).
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The hydrophobic, putatively membrane-anchored helices were found to be able to
bind NL-covered monolayers in vitro and localized to LDs in cells, when expressed
as individual peptides (Sui et al., 2018). Upon mutation of several hydrophobic
residues in these helices to aspartic acid, LD-localization could be inhibited. Whilst
mutating the hydrophobic helices was not alone sufficient to block seipin function in
cells, together with an additional deletion of the N-terminus of seipin, shown
previously to localize to LDs when expressed alone (Wang et al., 2016a), seipin
function in LD formation was impaired. Thus, the hydrophobic or amphipathic helices
of seipin, either in the luminal region or at the cytoplasmic N-terminus, may function
in recognizing the packing defects induced by local NL lenses in the ER bilayer and
thus allow for seipin stabilization at nascent LD formation sites (Sui et al., 2018).
During subsequent LD growth, this would place the seipin oligomer at the necks
between the ER and LDs, with a small part of the LD monolayer therefore derived
from the luminal leaflet of the ER, as suggested by EM tomography of seipin-mediated
ER-LD necks (study III, (Salo et al., 2019).
The bulk of the seipin luminal region consist of two beta sheets, which form a beta-
sandwich-like fold. This is structurally similar to many lipid-binding domains,
including that of NPC2 (Xu et al., 2007), a sterol binding protein in the lumen of the
lysosome, where it functions to bind cholesterol and aids in cholesterol export together
with NPC1 (Ikonen, 2018). Other proteins containing such domains include PKC,
which has a similar fold involved in PS binding (Lemmon, 2008). These structural
similarities suggest that seipin may be an ER luminal lipid-binding protein.  Indeed,
in vitro work indicated that both purified full-length seipin and a truncated variant
containing only the putative lipid binding domain could bind anionic PLs, such as PA,
but not other PLs, such as PC, PS or PE (Sui et al., 2018). Interestingly, the binding
for PA was dependent on the acyl-chains of PA, with seipin showing high affinity for
PA containing oleate and palmitate. The putative lipid binding domain is important
for seipin function, as a designed mutant, harboring two aa substitutions in the
hydrophobic cleft of the beta sandwich, was unable to complement the seipin KO LD
phenotype in cells (Sui et al., 2018). However, which lipids seipin binds or interacts
with in intact cells remains to be determined.
The luminal region of human seipin also contains a conserved, experimentally verified
N-glycosylation site (aa N88-S90, a N-X-V/S site). Although the detailed functional
significance of this site is unclear, mutations in it result in motor neuronal disease in
humans (discussed below in more detail). Furthermore, N-glycosylation deficient
seipin mutants have been shown to aggregate in cells, with increased localization to
ER domains adjacent to LDs (Hölttä-Vuori et al., 2013; Ito and Suzuki, 2007;
Windpassinger et al., 2004). The cryo-EM structures of seipin did not resolve the
glycan groups, so it is unclear how glycosylation may modify the structural properties
of the seipin oligomer.
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4.3.2 Seipin associated diseases
Mutations in seipin give rise to at least three distinct disease states in humans (Table
1). Various recessively inherited, loss-of-function of mutations give rise to BSCL2,
the most severe form of congenital lipodystrophy in humans (Magré et al., 2001).
Dominantly inherited, gain-of-function mutations in the N-glycosylation site of seipin
give rise to motor neuron disorders, hereditary spastic paraplegias with variable
phenotypes, collectively termed seipinopathies (Ito and Suzuki, 2009; Windpassinger
et al., 2004). Finally, mutations resulting in skipping of exon 7 of seipin, either
homozygously or in combination with a BSCL2-causing mutant, cause an early-onset,
fatal neurodegenerative disorder called Celia’s encephalopathy (Guillén-Navarro et
al., 2013).
Table 1. Mutations in seipin leading to disease. Fs denotes frameshift, numbered by first affected
aa, X denotes introduction of premature stop codon.
Disease Mutation Inheritance Notes Reference
BSCL2 lipodystrophy (select mutations)
T78A Recessive Only described in patients with
Q319X. Rescues LD defect in
yeast.
(Miranda et al., 2009; Wang
et al., 2014)
L91P Recessive Does not rescue LD defect in
yeast.
(Miranda et al., 2009; Wang
et al., 2014)
R138X Recessive (Magré et al., 2001)
Y187C Recessive Does not rescue LD defect in
yeast.
(Nishiyama et al., 2009;
Wang et al., 2014)
A212P Recessive Does not rescue LD defect in
yeast.
(Fei et al., 2008; Magré et
al., 2001)
L214fs Recessive (Magré et al., 2001)
Y225fs Recessive (Magré et al., 2001)
I262fs Recessive (Wu et al., 2009)
R275X Recessive Does not rescue LD defect in
yeast.
(Ebihara et al., 2004; Wang
et al., 2014)
Q391X Recessive Only described in patients with
T78A.
(Miranda et al., 2009)
Seipinopathy motor neuron disease
N88S Dominant Rescues LD defect in yeast. (Fei et al., 2008;
Windpassinger et al., 2004)
S90L Dominant Rescues LD defect in yeast. (Fei et al., 2008;
Windpassinger et al., 2004)
Celia encephalopathy, PELD
c.985C>T;
Y289LfsX64
Recessive/
Compound
(Guillén-Navarro et al.,
2013)
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4.3.2.1 Lipodystrophies and BSCL2
Lipodystrophies are a group of disorders characterized by loss of adipose tissue, with
concomitant metabolic disturbances such as insulin resistance, diabetes and
hyperlipidemia (Garg, 2004). Lipodystrophies are grouped into acquired and
congenital forms. Acquired lipodystrophy is most typically caused by HIV drug
treatments, especially protease inhibitors, and often involves adipose tissue loss from
the face, arms and legs together with insulin resistance and hyperlipidemia (Carr et
al., 1999). The molecular mechanisms behind HIV-related lipodystrophy are unclear
but may involve modulation of major adipogenic transcription factors (Garg, 2004;
Vigouroux et al., 2011). In rare cases, acquired lipodystrophy may also arise via
autoimmune mechanisms (Garg, 2004).
Congenital lipodystrophies are rare, monogenic diseases and they are further
categorized into partial (familial partial lipodystrophy, FPL) and generalized
(congenital generalized lipodystrophy, CGL) based on the severity and age-of-onset
of adipose tissue loss. CGL patients display generalized loss of body fat already at
birth, whilst FPL patients start to display partial loss of body fat during the first
decades of life (Garg and Agarwal, 2009). Besides lack of adipose tissue, CGL patients
typically develop severe insulin resistance, hypertriglyceridemia, hepatosteatosis and
may also display acanthosis nigricans, muscular hypertrophy, hepatomegaly and a
reduced life span (Magré et al., 2001). CGL diseases are also called Berardinelli-Seip
congenital lipodystrophies (BSCL), named after the researchers who first identified
the disease in the 1950s (Berardinelli, 1954; Seip, 1959). The estimated global
prevalence of BSCL lipodystrophies is around 1 per 10 million, with certain
geographic regions showing up to hundred-fold higher local prevalence (De Azevedo
Medeiros et al., 2017; Garg, 2004).
Although some affected loci likely still remain to be identified, most congenital
lipodystrophies are caused by mutations in genes encoding proteins involved in lipid
metabolism and LD biology (Table 2). (Krahmer et al., 2013a; Melvin et al., 2019;
Vigouroux et al., 2011). For example, mutations in AGPAT2, an enzyme catalyzing
LPA to PA conversion, leads to CGL (Agarwal et al., 2002). Interestingly, mutations
in lipin-1, an enzyme catalyzing PA to DAG conversion, lead to lipodystrophy in mice,
but not humans (Péterfy et al., 2001; Temprano et al., 2016; Zeharia et al., 2008).
Recently, mutations in the rate-limiting PC synthesis enzyme CCT-alpha were shown
to lead to a severe form of congenital lipodystrophy (Payne et al., 2014).  Somewhat
counterintuitively, also putative loss-of-function mutations in the lipase HSL have
recently been linked to FPL (Zolotov et al., 2017). These data highlight the importance
of PL and TAG metabolism in adipose tissue biology.
Mutations in several non-enzymatic proteins implicated in LD growth and stability,
such as perilipin-1, FSP-27 and seipin, lead to lipodystrophy (Gandotra et al., 2011;
Magré et al., 2001; Rubio-Cabezas et al., 2009). Mutations in Cav1 and Cavin1,
proteins implicated in caveolae assembly and possibly involved in intracellular FA
trafficking in adipose cells, also lead to forms of GCL (Cao et al., 2008; Dwianingsih
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et al., 2010; Hayashi et al., 2009; Kim et al., 2008; Shastry et al., 2010). Mutations in
proteins likely directly influencing adipocyte differentiation, rather than LD biology,
can also lead to congenital lipodystrophies. These include mutations in peroxisome
proliferator activated receptor-  (PPAR- ), a major adipogenic transcription factor
(Agarwal and Garg, 2002; Broekema et al., 2019) and mutations in proteins involved
in nuclear envelope integrity and insulin signaling, such as Lamin-A, ZMPSTE24 and
AKT (Melvin et al., 2019).
Table 2. Proteins implicated in congenital lipodystrophies.
Gene/Protein Protein function Disease Reference
AGPAT2/AGPAT2 Lipogenic enzyme, LPA to PA
conversion
CGL (Agarwal et al., 2002)
BSCL2/Seipin Unknown, ER-LD contact regulator CGL (Magré et al., 2001)
Cav1/Caveolin-1 Caveloae formation CGL (Kim et al., 2008)
PTRF/Cavin-1 Caveloae formation CGL (Hayashi et al., 2009)
PLIN1/Perilipin-1 LD coat protein, regulator of lipolysis FPL (Gandotra et al., 2011)
CIDEC-C/FSP-27 LD-LD contact protein, facilitates LD
growth
FPL (Rubio-Cabezas et al.,
2009)
LMNA/Lamin-A NE structural protein FPL (Cao, 2000)
PPAR / PPAR- Adipogenic transcription factor FPL (Agarwal and Garg, 2002)
ZMPSTE24/
ZMPSTE24
Lamin processing FPL (Agarwal et al., 2003a)
AKT2/AKT2 Involved in insulin signaling FPL (Tan et al., 2007a)
LIPE/HSL Lipase FPL (Zolotov et al., 2017)
CCT-alpha Rate-limiting enzyme of PC synthesis Unclassified (Payne et al., 2014)
The phenotype of seipin-caused BSCL2 is considered to be the most severe of the
known lipodystrophies. Whilst all CGL patients lack metabolically active adipose
tissue (e.g. subcutaneous, visceral, and bone marrow fat), BSCL2 patients typically
also lack “mechanical” fat deposits (e.g. retro-orbital and periarticular fat) and show
earlier onset of diabetes and other metabolic comorbidities (Agarwal et al., 2003b;
Van Maldergem et al., 2002; Simha and Garg, 2003). BSCL2 patients also have an
increased risk of hypertrophic cardiomyopathy and mild to moderate mental
retardation in comparison with other CGL patients (Agarwal et al., 2003b; Cartwright
and Goodman, 2012; Van Maldergem et al., 2002; Simha and Garg, 2003).
Furthermore, BSCL2 has been linked to teratospermia (Jiang et al., 2014) and
mitochondrial dysfunction (Jeninga et al., 2012). These unique characteristics of
BSLC2 lipodystrophy compared to other forms of CGL may relate to seipin function
outside of adipocytes, in line with high expression level of the protein in brain tissues
and testes (Cartwright and Goodman, 2012; Magré et al., 2001).
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4.3.2.2 Seipin and neuronal disorders
Whereas loss-of-function mutations in seipin give rise to BSCL2, gain-of-function
mutations in the ER luminal N-glycosylation motif of seipin (N88S and S90L) give
rise to dominantly inherited motor neuronal disorders, collectively now termed
seipinopathies (Ito and Suzuki, 2009; Windpassinger et al., 2004). The clinical
spectrum of this disease is broad and heterogenous, with upper and/or lower motor
neurons affected to varying degrees in lower and/or upper extremities, typically
without major afflictions in sensory neurons (Auer-Grumbach et al., 2005; Ito and
Suzuki, 2009; Windpassinger et al., 2004). Thus, though seipinopathy refers to the
genetic diagnosis, patients may clinically be diagnosed with Silver syndrome (main
phenotype: weakness and wasting in the small hand muscles and spasticity of the
lower limbs), distal hereditary motor neuropathy type V (weakness and wasting in the
small hand muscles), hereditary spastic paraplegia (spastic paraplegia in the lower
limbs) or Charcot-Marie-Tooth disease type 2 (distal muscle weakness, wasting of the
upper and lower limbs) (Ito and Suzuki, 2009). A subset of patients harboring a
mutation may be asymptomatic or display only minor abnormalities and the
penetrance and severity of the disease varies even within a common pedigree (Auer-
Grumbach et al., 2005). Seipinopathy patients have not been reported to display signs
of lipodystrophy.
Whilst the molecular pathogenesis of seipinopathy is unclear, cell biological work has
shown that the seipin N-glycosylation mutants lead to UPR, protein aggregation and
ER stress (Hölttä-Vuori et al., 2013; Ito and Suzuki, 2007; Ito et al., 2012;
Windpassinger et al., 2004). Overexpression of N88S seipin also leads to motor
neuron dysfunction and ER stress in mice and a swimming defect in developing
zebrafish embryos (Hölttä-Vuori et al., 2013; Yagi et al., 2011). In these studies,
neuronal cell death was not observed, suggesting ER stress alone is sufficient to induce
symptoms. However, another study in transgenic mice reported N88S overexpression
to induce cell death in the spinal cord together with increased autophagy (Guo et al.,
2013). Overall, seipinopathy may arise via toxic accumulation of the protein which
could be especially harmful in sensitive cells, such as motor neurons.
Seipin may also play important physiological roles in neuronal cells, which could be
disrupted by the N-glycosylation mutations. Indeed, mouse studies have linked seipin
function to neuronal function via control of PPAR- , with neuronal-specific seipin KO
mice displaying increased susceptibility to beta-amyloid induced neuroinflammation
and tau aggregation (Chang et al., 2019; Wang et al., 2018a). Loss of seipin in mice
also increased cerebral ischemia/reperfusion damage (Chen et al., 2016), decreased
excitatory post-synaptic currents in neuronal mouse model (Wei et al., 2013), and
reduced axonal regeneration in a Drosophila model (Rao et al., 2016). Together with
the frequently observed cognitive impairment in BSLC2 patients, these studies suggest
that seipin may play a neuroprotective role. Considering that both N88S- and WT-
seipin can readily co-immunoprecipitate with each other (Fei et al., 2011b), it may be
that seipinopathy arises via a loss-of-function mechanism exacerbated by the
propensity of N88S to form protein aggregates.
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Further implications for the role of seipin in neuronal function comes from the recent
discovery of Celia’s encephalopathy, also called progressive encephalopathy with or
without lipodystrophy (PELD) (Guillén-Navarro et al., 2013; Ruiz-Riquelme et al.,
2015). Patients suffering from this extremely rare disease (less than 10 cases described
so far in the literature) are initially healthy, but start to show signs of psychomotor
delay by the age of two years, with subsequent progressive encephalopathy and
complex neurological symptoms, leading to death in the first decade of life (Guillén-
Navarro et al., 2013). PELD is caused by a mutation in the coding DNA of seipin
(c.985C>T), resulting in aberrant splicing leading to the skipping of exon 7 and the
production of a new aberrant protein, called Celia-seipin, which lacks the second TM
domain and distal C-terminal cytoplasmic region. Heterozygous carriers of this variant
are healthy, whilst homozygotes are inflicted. Interestingly, this variant also leads to
the disease in patients carrying a BSCL2-lipodystrophy (loss-of-function) linked-
mutation in the other allele, and these patients also show classic signs of CGL
(Guillén-Navarro et al., 2013). Subsequent analysis has documented that also other
nearby mutations may interfere with this splicing site, leading to various clinical
phenotypes, ranging from PELD to BSCL2 with various levels of cognitive
impairment and neurological symptoms (Sánchez-Iglesias et al., 2019).
Cell biological studies have suggested that Celia seipin can form larger oligomers than
WT-seipin, whilst co-overexpression of WT- and Celia-seipin reduces oligomer sizes
to normal (Ruiz-Riquelme et al., 2015). Aggregates of Celia-seipin were detected in a
PLD patient brain biopsy by immunohistochemistry, and these are postulated to lead
to ER stress in neurons (Ruiz-Riquelme et al., 2015). These data suggest a toxic gain-
of-function, which may be prevented in heterozygote carriers by the presence of WT
seipin (Ruiz-Riquelme et al., 2015; Sarmento et al., 2018), although further studies
into the pathogenesis of this devastating disease are needed.
4.3.3 Seipin function
Despite a clear role in both adipogenesis and LD formation, the molecular role(s) of
seipin remains to be identified. Indeed, considering the pleiotropic diseases associated
with seipin mutations and its tissue-wide expression pattern, seipin likely has multiple
different functions, perhaps in a cell-type dependent manner. Seipin appears to have a
primary and evolutionary conserved role in LD formation and perhaps an additional
role specific to adipocyte differentiation. However, as these processes are intimately
linked and yet incompletely understood, a common molecular function could be in
play at both phenomena. Indeed, whether impaired LD biogenesis and/or LD
maintenance leads to impaired adipogenesis, is thus far unresolved (Qi et al., 2017).
Many interaction partners have been proposed for seipin, including lipogenic
enzymes, calcium channels, ER-shaping proteins and cytoskeleton regulators (Table
3) indicating involvement in multiple cellular pathways. With the exception of GPAT
and promethin (Castro et al., 2019; Pagac et al., 2016), these interactions have not
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been documented in both yeast and mammalian systems, raising the question how
relevant they are for the function of seipin in LD formation. Indeed, the striking ability
of human seipin to rescue the yeast seipin KO LD phenotype suggests that if this is
function requires a specific seipin-protein interaction, it should also be broadly
conserved. This would be somewhat surprising, considering the large deviation in
primary sequences between human and yeast seipin, and the fact that the yeast seipin
complex is composed of two distinct proteins and loss of both can be compensated by
human seipin (Wang et al., 2014).  Indeed, some of the proposed seipin interactions in
mammalian cells may relate to seipin function outside of LD formation, such as
regulating adipogenesis. Some proposed functions for seipin are reviewed below.
Table 3. Proposed interaction partners of seipin. Yeast protein names in italics. Co-ip, co-
immunoprecipitation.
Protein
name
Protein function Main evidence for
interaction
Proposed function
of interaction
Reference
Ldb16 Regulator of LD
morphology
Co-ip: endogenous proteins
in yeast
Forms a complex
with seipin to
regulate LDs
(Cartwright et al.,
2015; Wang et al.,
2014; Wolinski et
al., 2015)
Promethin/
Ldo45
Ldo16
Regulator of LD
identity (yeast)
Co-ip: endogenous proteins
(yeast), overexpressed
proteins (human cells)
Unclear, seipin may
regulate localization
(Castro et al., 2019;
Eisenberg-Bord et
al., 2018; Teixeira
et al., 2018)
GPAT3-4/
Get1-2
Catalyzes G3P to
LPA converstion
Co-ip: endogenous proteins
(yeast), overexpressed
proteins (murine cells)
Seipin negatively
regulates GPAT
enzyme activity
(Pagac et al., 2016)
SERCA ER calcium
pump, transports
Ca+2 into ER
lumen
Co-ip: endogenous proteins
(human cells),
overexpressed proteins
(Drosophila cells)
Seipin positively
regulates SERCA
activity
(Bi et al., 2014)
Lipin-1 Catalyzes PA to
DAG conversion
Co-ip and AFM:
overexpressed proteins
(murine cells)
Seipin recruits lipin
to the ER membrane
(Sim et al., 2012;
Talukder et al.,
2015)
AGPAT-2 Catalyzes LPA to
PA conversion
Co-ip and AFM:
overexpressed proteins
(murine cells)
Scaffolding of
lipogenic enzymes
(Sim et al., 2012;
Talukder et al.,
2015)
14-3-3- A scaffolding
protein, signal
transduction
Co-ip: overexpressed
proteins (murine and human
cells)
Cytoskeleton
remodeling
(Yang et al., 2014)
Perilipin-2 LD coat protein,
lipolysis regulator
Co-ip: overexpressed
proteins (human cells)
Seipin regulates
perilipin-2
localization to LDs
(Mori et al., 2016)
Perilipin-1 LD coat
protein, lipolysis
regulator
Co-ip and AFM:
overexpressed proteins
(human cells)
Seipin regulates
perilipin-1
localization to LDs
(Jiao et al., 2019)
Reep-1 Regulates
ER morphology
Co-ip: overexpressed
proteins (murine cells)
Unclear (Renvoisé et al.,
2016)
4.3.4 Seipin, adipogenesis and metabolic dysfunction
Several independent KO mouse models for BSCL2 lipodystrophy have been
generated. These all exhibit a phenotype mostly consistent with that observed in
humans, with lipodystrophy, insulin resistance and fatty liver (Chen et al., 2012; Cui
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et al., 2011; Prieur et al., 2013). However, in contrast to BSLC2 patients,
hypertriglyceridemia is not observed in mice, which has been attributed to increased
uptake of TAG-rich lipoproteins and FAs by the liver (Dollet et al., 2014; Prieur et al.,
2013). Indeed, seipin may play different roles in liver function in humans vs rodents,
as liver-specific seipin-ablated mice displayed no metabolic phenotype (Chen et al.,
2014), whilst cellular studies have shown a role for seipin in hepatocyte lipid
metabolism (Amine et al., 2017; Li et al., 2019a).
Several adipocyte-specific KO mouse models for seipin have also been investigated.
These all develop lipodystrophy with greatly reduced fat mass (Liu et al., 2014;
Mcilroy et al., 2018; Zhou et al., 2015), suggesting seipin is tissue-autonomously
crucial for adipose tissue development and maintenance. It is somewhat unclear to
what extent the other metabolic phenotypes can be attributed to adipose tissue loss
only. Constitutive ablation of seipin in mature mouse adipose tissue was sufficient to
induce both progressive adipose tissue loss, insulin resistance and hepatic steatosis
(Liu et al., 2014) and these phenotypes in a global seipin KO model could be rescued
by re-expression of seipin in adipose tissue alone (Gao et al., 2015). However, in
inducible adipose-tissue specific KO mouse, the authors observed only severe fat loss
without insulin resistance or hepatic steatosis (Zhou et al., 2015). Finally, a recent
study employing constitutive seipin depletion specifically in developing mouse
adipocyte tissue described early-onset, generalized lipodystrophy and altered fuel
utilization without severe metabolic disturbances (Mcilroy et al., 2018).  Overall, these
studies suggest that whilst seipin is critical for adipocyte function and adipose tissue
plays a major role in organismal energy homeostasis, seipin plays important metabolic
roles also in other tissues.
Indeed, seipin KO mouse models have proved to be a valuable tool to dissect the
contributions of adipose tissue loss to the pathogenesis of other diseases, such as
cardiomyopathy and atherosclerosis (Joubert et al., 2017; Wang et al., 2016b). For
example, the cardiomyopathy associated with BSCL2 patients and also detected in
seipin KO mouse could be alleviated by efficient treatment of hyperglycemia via
dapagliflozin, suggesting hyperglycemia plays a key role in the development of this
cardiac dysfunction (Joubert et al., 2017). Furthermore, seipin KO exacerbated the
development of atherosclerotic lesions in several atherogenic mouse models (Liao et
al., 2018; Wang et al., 2016b), highlighting the importance of adipose tissue and seipin
in this common disease.
The reasons behind impaired adipogenesis in the absence of seipin are unclear. Early
studies utilizing cultured mouse preadipocyte cells (3T3-LI) and mesenchymal stem
cells found seipin to be upregulated during adipogenesis and indispensable for
adipogenic differentiation (Chen et al., 2009; Payne et al., 2008). Impaired adipogenic
capacity has also been documented in seipin KO mouse embryonic fibroblasts (MEFs)
and induced pluripotent stem cells from BSCL2 patients (Chen et al., 2012; Mori et
al., 2016). Mechanistically, this defect appears to be evident not during stem cell
commitment to preadipocyte lineage, but rather during the early stages of preadipocyte
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differentiation (Chen et al., 2009). Interestingly, LD biogenesis is impaired (with
supersized and tiny LDs) also during early time points of adipogenesis differentiation
in BSCL2 KO MEFs, and this morphological defect precedes alterations in canonical
adipocyte differentiation marker levels (such as PPAR- , see below) (Chen et al.,
2012).
Multiple studies have suggested PPAR-  signaling to be affected via seipin ablation,
with seipin required to activate and/or sustain PPAR-  signaling during adipogenesis
(Chen et al., 2009; Prieur et al., 2013). In line with this, supplementation with PPAR-
 agonists has been shown to partially rescue the adipogenic defects in seipin
knockdown 3T3-LI cells and seipin KO MEFs in some studies (Chen et al., 2009;
Prieur et al., 2013), but not in others (Chen et al., 2012). PPAR-  agonists also
improved metabolic disturbances, including insulin resistance, in seipin KO mouse
models (Liu et al., 2014; Prieur et al., 2013). These findings, together with evidence
from various cellular models implicating seipin in PA metabolism (see below), have
led to a hypothesis suggesting that seipin may function during early adipogenesis to
prevent a toxic metabolite, probably PA, from accumulating at an undesired cellular
localization and interfering with PPAR-  (Gao et al., 2019; Liu et al., 2014). However,
induced pluripotent stem cells from BSCL2 patients failed to develop into adipocytes
in the presence of PPAR-  activator (Mori et al., 2016).
Unrestrained cAMP/PKA signaling and increased lipolysis has also been documented
in seipin KO adipocyte-differentiating MEFs and mature adipocytes (Chen et al.,
2012; Prieur et al., 2013; Zhou et al., 2015). Indeed, in adipocyte-differentiating seipin
KO cells, lipolysis mediators such as perilipin-1 and HSL were hyper-phosphorylated
at PKA-mediated sites concomitant with increased lipolysis. Thus, through currently
unclear mechanisms, seipin deficient cells exhibit constitutive and unrestrained
lipolysis, leading to breakdown in TAG storage (Chen et al., 2012). In line with this,
studies have proposed seipin to interact directly with Perilipin 1 and Perilipin 2, both
known regulators of lipolysis (Jiao et al., 2019; Mori et al., 2016). A recent study also
demonstrated partial alleviation of lipodystrophy in seipin KO mice via inhibition of
ATGL (Zhou et al., 2019). Unrestrained PKA-signaling has also previously been
reported to perturb adipogenesis, independently of seipin  (Li et al., 2010).
However, increased lipolysis is not a universal feature of seipin depleted cells. It was
not observed in Drosophila seipin KO fat body nor in non-adipogenic human seipin-
ablated cells (Ding et al., 2018; Liu et al., 2014; Salo et al., 2019) and lipolysis was
conversely decreased in mature seipin-deficient adipocytes and yeast seipin KO cells
(Fei et al., 2011c; Liu et al., 2014; Wolinski et al., 2011). Overall, these data implicate
the effect of seipin on lipolysis is likely tissue/cell-type specific or it may be indicative
of a yet unidentified up-stream phenomenon. However, lipolysis may well be a major
culprit of the defective adipogenesis and as such a potential therapeutic target in
lipodystrophy patients.
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4.3.5 Seipin as a regulator of actin dynamics and calcium flux
Seipin has also been proposed to regulate adipogenesis via remodeling of the actin
cytoskeleton, through a direct interaction with 14-3-3-  through seipin’s cytoplasmic
termini (Yang et al., 2014). In this model, seipin would transfer ER-derived lipid
storage signals to the actin cytoskeleton through the scaffold protein 14-3-3-  and its
client cofilin-1, enabling the extensive remodeling of actin required for adipocyte
development (Yang et al., 2014). Whilst a number of recent studies have linked actin
remodeling to adipogenesis, insulin resistance and LD storage (Kim et al., 2019;
Pfisterer et al., 2017; Tharp et al., 2018), the precise role of seipin in regulating
cytoskeleton elements is unclear.
Seipin has also been proposed to regulate fat storage via modulation of intracellular
calcium levels (Bi et al., 2014; Ding et al., 2018). Seipin was found to physically
interact with the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) in both
Drosophila and human cells (Bi et al., 2014). SERCA activity and ER calcium levels
were reduced in seipin KO flies and SERCA disruption in Drosophila fat body cells
led to reduced lipid storage similar to seipin KO. Interestingly, the reduced lipid
storage of seipin KO flies could partially be alleviated by concomitant disruption of
an ER-to-cytosol calcium pump, RyR, suggesting reduced ER calcium levels are
important for fat storage. In a follow-up study, seipin was also found to be important
for the maintenance of mitochondrial calcium homeostasis (Ding et al., 2018). Seipin
KO fat body cells displayed altered mitochondrial function, and reducing
mitochondrial calcium export could partially alleviate the lipid storage defects in
seipin mutants (Ding et al., 2018). Although the molecular mechanisms by which
seipin influences SERCA activity and/or mitochondrial calcium levels are unclear, a
recent study also linked seipin to alterations in calcium metabolism in human liver
cancer cells (Li et al., 2019b).
4.3.6 Seipin and LDs
Seipin perturbation leads to impaired LD assembly in multiple model systems, with a
phenotype of small and supersized LDs. Other features include delayed LD formation,
aberrant LD protein composition and dysfunctional and morphologically abnormal
ER-LD contacts (Chen and Goodman, 2017). Two emerging hypotheses have been
proposed to account for these observed effects. Seipin may primarily function to
control LD formation via modulation of PL metabolism and/or PL distribution at the
ER, or ascertain its function via control of ER-LD contacts and LD forming sites,
perhaps acting as a structural component and/or diffusion barrier (Chen and Goodman,
2017; Gao et al., 2019). Data for these hypotheses, which are naturally not mutually
exclusive, is briefly discussed below.
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4.3.6.1 Seipin as a modulator of cellular lipid metabolism
Seipin is likely a non-enzymatic protein, as no enzymatic domains have thus far been
identified in it. However, the dramatic effects of seipin loss on LDs and adipogenesis
have led to thorough investigation of the consequences of seipin ablation on cellular
lipid metabolism. Unfortunately, consistent, robust aberrations in seipin depleted
lipidomes have not yet been uncovered, except for the global decrease of NLs in
lipodystrophy patients and BSCL2 animal models lacking adipose tissue. For
example, considering the cellular levels of TAG in the absence of seipin, some yeast
studies have reported increased levels (Fei et al., 2008, 2011c), whilst others have
detected a decrease ((Gao et al., 2017b; Han et al., 2015) or no alterations (Grippa et
al., 2015; Wang et al., 2014). Similarly in mammalian studies of non-adipocyte cells,
seipin depletion leads to both decreased (Boutet et al., 2009; Hölttä-Vuori et al., 2013;
Salo et al., 2016) and increased (Fei et al., 2011b) levels of TAG, and other studies
have detected no change (Wang et al., 2016a). Also robust alterations in cellular PL
levels have not been detected in response to acute or chronic seipin depletion (Fei et
al., 2008, 2011c; Grippa et al., 2015; Salo et al., 2019; Wang et al., 2014, 2016a).
Studies have documented alterations in yeast and human lipidome saturation indexes
in seipin deficiency (Boutet et al., 2009; Fei et al., 2008), implicating decreased SCD1
activity, while other studies have failed to uncover robust changes in these parameters
(Salo et al., 2019; Wang et al., 2016a).
An especially interesting lipid in this context is PA, a putative binding client for seipin
(Yan et al., 2018). PA levels are increased in the absence of seipin in many model
systems, such as yeast microsomes (Fei et al., 2011c), Drosophila larvae (Tian et al.,
2011), mouse testes (Jiang et al., 2014), mature seipin depleted mouse adipose tissue
(Liu et al., 2014) and 3T3-Li preadipocyte microsomes (Pagac et al., 2016). On the
other hand, others have failed to detect differences in cellular PA levels even in the
presence of a robust LD phenotype, arguing that global PA handling may not be the
culprit of seipin deficiency (Grippa et al., 2015; Wang et al., 2016a). However, this
does not rule out a role of seipin in locally controlling PA metabolism at the ER. This
notion is supported by the discovery that multiple PA-sensing fluorescent probes
accumulate at distinct LD-associated ER foci in yeast seipin KO cells, suggesting
localized PA accumulation (Grippa et al., 2015; Han et al., 2015; Wolinski et al.,
2015). It should be noted, however, that such accumulates were not observed in
mammalian seipin KO cells (Wang et al., 2016a), and Grippa and colleagues
postulated that these PA-probes may in fact be reporting localized PL packing defects,
rather than PA accumulation (Grippa et al., 2015; Horchani et al., 2014).
Seipin has been proposed to control cellular PL and/or TAG metabolism via direct
interactions with multiple lipogenic enzymes, including AGPAT2 (Talukder et al.,
2015), lipin-1 (Sim et al., 2012) and GPATs (Pagac et al., 2016). Through immuno-
purification of co-overexpressed proteins and AFM studies, single seipin oligomers
were shown to be able to bind both AGPAT2 and lipin-1 at the same time. In
developing adipocytes, the seipin-lipin-1 interaction was increased in response to
exogenous FAs, and a forced stabilization of the AGPAT2-seipin interaction increased
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cellular PPAR-  expression in the nucleus (Sim et al., 2012; Talukder et al., 2015).
These data indicate that seipin may act as a scaffold for these enzymes, facilitating
lipid flux from enzyme to enzyme, which would be essential during conditions of high
lipogenesis, such as adipogenesis (Talukder et al., 2015). This mechanism may not be
involved in regulating the core function of seipin in LD formation, as the cytoplasmic
N- and C-termini of seipin (crucial for lipin-1 binding in human cells) are
evolutionarily poorly conserved and not necessary for seipin function in yeast (Wang
et al., 2014; Yang et al., 2013). However, disrupted lipid flux between AGPAT and
lipin enzymes could explain the increased levels of local PA. Importantly, AGPAT2
mutations also lead to lipodystrophy in humans, similar to seipin, and loss of lipin-1
function leads to lipodystrophy in mice (Melvin et al., 2019).
In contrast to a facilitatory role for seipin in AGPAT2-lipin1 mediated lipid flux, the
interaction between seipin and GPAT is proposed to be inhibitory in nature (Pagac et
al., 2016). In this study, the authors demonstrated that GPAT activity is
altered/increased in multiple seipin depleted systems. Seipin was proposed to control
GPAT activity and thereby prevent aberrant LD expansion. Whilst the molecular
underpinnings of this interaction are unclear, inhibiting GPAT activity was also shown
to partially alleviate defective adipogenesis in seipin-deficient cells (Pagac et al.,
2016). Importantly, this interaction was observed in both yeast and mammalian
preadipocyte systems, arguing for a conserved role in both LD formation and
adipogenesis. These data lend further support for the model (discussed above) of a
toxic lipid ligand, dependent on the inhibitory action of seipin on GPAT activity, being
the culprit of defective adipogenesis in the absence of seipin (Pagac et al., 2016).
Furthermore, this model is supported by seipin’s capability of binding anionic PLs,
such as PA (Yan et al., 2018) and observations that overexpression of seipin can inhibit
LD formation in mammalian cells (Fei et al., 2011b; Yang et al., 2013). However, why
seipin would directly need to inhibit GPATs to allow for growth of seipin-associated
LDs, as reported recently (Cao et al., 2019; Salo et al., 2019), remains to be uncovered.
4.3.6.2 Seipin as a stabilizer of LD formation sites and ER-LD contacts
In the absence of robust global lipidomic changes in seipin deficient cells, a more
discrete role for seipin in structurally regulating ER-LD contacts and the identity of
LDs has been proposed. In this model, seipin may not primarily control lipid synthesis
or degradation, but rather controls the flow of lipids (NLs, PLs or both) between these
two organelles. This notion is supported by the localization of the seipin complex at
ER-LD contact sites and the defects of LDs and ER-LD contacts in its absence (Fei et
al., 2008; Grippa et al., 2015; Salo et al., 2019, 2016; Szymanski et al., 2007; Wang et
al., 2016a). However, what exactly seipin regulates at ER-LD contacts is unclear.
Indeed, although recent studies have clearly shown a LD-autonomous growth-
promoting function for both C. elegans and human seipin (Cao et al., 2019; Salo et al.,
2019), this could be achieved via many different mechanisms.
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In yeast, seipin KO leads to a phenotype where some cells accumulate supersized LDs
(SLDs), whilst others display aggregated small LDs often entangled in the ER network
(Cartwright et al., 2015; Grippa et al., 2015; Szymanski et al., 2007; Wolinski et al.,
2011). A number of other yeast mutants also display SLDs, and these have been
attributed to alterations in PE/PC ratios and increased PA levels (Fei et al., 2011c).
However, the LD phenotype of seipin KO is different from these mutants, as the LD
morphology cannot be rescued by supplementation with PL precursors. Instead of
reverting to normal sized LDs of WT cells, stimulation of PL synthesis in seipin
mutants leads to a higher fraction of small, aggregated LDs (Cartwright et al., 2015;
Grippa et al., 2015; Wang et al., 2014). These data suggest seipin may function to
uncouple LD growth from ER PL pools, as the excess PL leads to numerous tiny LDs.
It has thus been proposed that in the absence of seipin LD morphology is solely
dependent on available PLs in the ER (Grippa et al., 2015; Wang et al., 2018b).
This elegant notion is further supported by observations that the SLDs and small
aggregated LDs appear to have different monolayer features, with small LDs
displaying monolayer packing defects recognized by typically non-LD resident
proteins, whilst the SLDs have a higher surface tension, more similar to normal WT
LDs (Grippa et al., 2015). Indeed, defective targeting of various LD-localized proteins
have been noted in multiple seipin KO models, including mammalian cells (Salo et
al., 2016; Wang et al., 2016a). For example, a subset of LDs in seipin depleted
Drosophila cells acquire machinery for local TAG synthesis prematurely, leading to
their aberrant expansion (Wang et al., 2016a), whilst growth-abortive tiny LDs of
human seipin KO cells fail to acquire ACSL3, a key acyltransferase important for LD
growth (Salo et al., 2016). These targeting defects may arise due to alterations in LD
monolayer properties. Overall, seipin may function to control the monolayer surface
tension of LDs via ER-LD contacts by acting as a diffusion barrier (Grippa et al.,
2015). Whilst this function would explain many of the observed LD defects in seipin
deficient cells, whether it controls primarily PL, NL or protein flux, is unclear.
Seipin has recently been linked to control of LD diversification in yeast cells. During
nutritional stress, yeast cells expand their ER-vacuole contact sites, which also serve
as a site for LD production in these conditions (Hariri et al., 2017). These ER-vacuole
contact site-associated LDs, which represent a unique LD subpopulation, can be
modulated by protein factors Ldo45/Ldo16, which interact with seipin (Eisenberg-
Bord et al., 2018; Teixeira et al., 2018). A human homolog of Ldo45/Ldo16 called
promethin could also be co-immunoprecipitated by seipin in co-overexpression
experiments, and its localization to LDs was regulated by seipin expression levels
(Castro et al., 2019). As the Ldo45/Ldo16 proteins are modulated by nutritional
conditions (Teixeira et al., 2018), they may assert an additional layer of control over
seipin-mediated ER-LD contacts.
Seipin may also physically help to tether the ER and LDs together, facilitating the
formation of membrane bridges (Salo et al., 2019). This notion is supported by the
observation that a subset of LDs detach completely from the ER in the absence of
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seipin in both yeast and mammalian cells (Chen and Goodman, 2017; Han et al., 2015;
Salo et al., 2016), a phenomenon not described in WT cells or any other mutants. In
line with this, LD inheritance between yeast mother and daughter cells is disturbed in
seipin KO, owing likely to disrupted ER-LD connections (Wolinski et al., 2011).
However, most LDs even in the absence of seipin retain contacts with the ER (Salo et
al., 2016; Wang et al., 2016a), likely due to other tethering factors, such as Rab18 and
snx14. However, these remaining contacts are apparently not sufficient to ensure
controlled LD growth in the absence of seipin.
The defective LDs of seipin KO cells may also be a consequence of defective initial
LD biogenesis. Indeed, in a yeast system where NL synthesis was held constant, LD
biogenesis was severely delayed in seipin deficient cells (Cartwright et al., 2015). The
authors also observed a defect in NL partitioning between the ER and LDs, with
relative accumulation of TAG in membranes, concomitant with appearance of tiny,
de-novo LDs. Tiny, growth-abortive LDs are also generated in seipin KO mammalian
cells during de novo lipogenesis (Salo et al., 2016; Wang et al., 2016a). These data
suggest that in the absence of seipin, LDs may spontaneously “oil out” of the ER,
suggesting seipin could regulate NL flux from the ER to LDs. This notion is supported
by FRAP experiments of FA analogs in acutely seipin depleted cells (Salo et al., 2019)
as well as ultrastructural evidence of electrolucent (i.e. lipid-like) material
accumulating in LD-proximal ER regions (Grippa et al., 2015) and a widening of ER
width in lipid-challenged mammalian seipin KO cells (Salo et al., 2016). This “oiling
out”, could be a consequence of deficient platform assembly for LD formation in the
absence of seipin (discussed in more detail in Results and discussion).
Whilst the LD phenotype of seipin deficient yeast cells is overall similar to what has
been reported in mammalian cells, there are a few notable differences. In mammalian
cell systems both SLDs and aggregated LDs are typically seen in the same cell, whilst
in yeast there is more cell-to-cell heterogeneity (Chen and Goodman, 2017). A
possible explanation is the more complex architecture and larger size of mammalian
ER, where more diverse lipid subdomains may exist within single cells. Furthermore,
yeast seipin mutants typically display tangles of ER networks in close proximity to
aggregated LDs, a phenotype not reported in mammalian cells (Grippa et al., 2015;
Salo et al., 2016; Wolinski et al., 2011). Similar aggregates could also be induced in
WT yeast cells via forcing increased LD generation by growing cells in OA-containing
medium (Chorlay et al., 2019; Wolinski et al., 2015). As the ER morphology is normal
in seipin KO mammalian cells (Wang et al., 2016a), these differences may stem from
differences in ER regulating factors, indicating higher adaptivity of the mammalian
ER network. In line with this, seipin deficiency sensitizes yeast, but not mammalian
cells to ER stress (Wang et al., 2016a; Wolinski et al., 2015). It should be noted,
however, that seipin has been proposed to interact with ER-shaping proteins in both
yeast and mammalian systems (Renvoisé et al., 2016; Wang et al., 2018b).
Perhaps the most striking difference between yeast and mammalian systems in relation
to seipin biology is the observation that in yeast systems almost all seipin foci localize
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at ER-LD contacts (Wang et al., 2014), whilst in mammalian cells there are typically
many more seipins than LDs, and a high fraction of seipins reside in the ER, outside
of ER-LD contacts (Salo et al., 2016; Wang et al., 2016a). This strongly suggests that
at least in mammalian cells, seipin likely plays roles outside of ER-LD junctions,
possibly modulating Ca2+ flux, ER PL metabolism or other functions. The specific
function of non ER-LD-junction associated seipin foci has thus far not been clarified.
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5 AIMS OF THE STUDY
The aim of this study was to elucidate the role of seipin in organizing lipogenic
subdomains of the ER and decipher how its function is disrupted in diseases caused
by seipin mutations. Specific aims of the study are listed below:
In the first study, we aimed to shed light on the pathogenesis of seipinopathy, caused
by the N-glycosylation defective N88S-seipin. We utilized cells of CNS origin and
developing zebrafish larvae to ectopically overexpress N88S and characterize its
subcellular localization and effects on NL storage. We also investigated the interplay
between LDs and ER stress pathways in these systems.
In the second study, we sought to characterize the role of seipin in LD formation and
investigate mechanisms leading to lipodystrophy in its absence. By employing
CRISPR/Cas9 mediated genome editing in combination with advanced imaging
techniques, we investigated the subcellular localization of endogenous seipin and the
consequences of seipin loss in human cells.
In the third study, we aimed to define the ultrastructure of seipin-mediated ER-LD
contacts sites and investigate seipin’s role in regulating NL flux between the ER and
LDs.
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6 METHODS
Methods used in this thesis are summarized in Table 4. Detailed Materials and
Methods are presented in the original publications (I-III), and some methodical
considerations are presented here.
Table 4. List of main methods used in this thesis.
Method Study
3D-SIM microscopy II
Adenovirus-mediated silencing III
Airyscan super resolution live and fixed cell microscopy II, III
Auxin-induced degradation of intracellular proteins III
CLEM III
Click-chemistry analyses of FA flux II, III
Electron tomography II, III
Fluorescence recovery after photobleaching (FRAP) II, III
Generation of stable cell lines II, III
GUV preparation and model membrane studies III
HPTLC lipid analysis I, II, III
Image analysis (ImageJ, Huygens, iIlastik, MatLab, CellProfiler, Icy) I, II, III
Immuno-EM II
Immunoblotting I, II, III
Immunofluorescence I, II, III
Laser scanning confocal microscopy I, II, III
LD isolation I, III
Lipid mass spectrometry III
Mammalian cell culture and transfection I, II, III
Molecular cloning I, II, III
PCR II, III
Retrovirus-mediated ectopic expression II
Statistical analysis I, II, III
Stochastic optical reconstruction microscopy (STORM) II
Widefield live and fixed cell microscopy II, III
Zebrafish maintenance, microinjections and swimming experiments I
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6.1.1 Model systems
In these studies, we utilized multiple immortalized cell lines, including human
astrocytoma (U251 MG), murine neuronal-like (NSC-34) and human epidermoid
carcinoma cells (A431). Most extensively we employed A431 cells. These are fast
growing, genetically malleable and metabolically active cells, and have extensively
been used for LD studies by us and others (Heybrock et al., 2019; Moessinger et al.,
2011; Salo et al., 2016). Using highly proliferative cells was necessary as many of our
techniques (such as CRISPR-mediated gene KO and endogenous tagging) involve the
generation of stable, genetically modified cell lines. The duration of stable cell line
generation via limiting dilution is dependent on the growth rate of the cell lines used.
Whilst drawing conclusions for normal physiology from cancer cells is always risky,
the mechanisms involved in LD assembly appear broadly conserved amongst cell
types. Furthermore, we also validated our key findings using non-transformed cells,
primary and BSCL2 patient-derived fibroblasts. In study I, we also employed an in
vivo system, developing zebrafish and in study III, an in vitro system of giant
unilamellar vesicles (GUVs).
An important aspect of the studies presented here is tight control of the metabolic
status of the cells. Typically for LD studies in mammalian cells, cells are treated with
high concentrations of extracellular FAs (Guo et al., 2008; Kuerschner et al., 2008)
and we used oleic acid (OA) for this purpose (I-III). OA treatment readily induces LD
formation. However, as we were especially interested in the early steps of LD
biogenesis (II-III), it was important to create a starting condition where the cells would
not initially contain any pre-existing LDs. To achieve this, we first stringently starved
the cells by culturing them for several days in a medium which lacked extracellular
FAs (i.e. lipoprotein deficient serum containing medium, LPDS). During this
treatment, cells efficiently metabolize their pre-existing LDs, presumably to use the
liberated FAs for energy production and as membrane precursors for cell proliferation.
Thus, upon pre-treatment of cells with LPDS and subsequent OA treatment, we could
ensure the LDs we were observing were generated de novo. To further improve the
stringency of the starvation, we also employed DGAT1 and DGAT2 inhibitors in
study III.
Previous studies have utilized starvation protocols in serum free medium to reduce LD
numbers (Kassan et al., 2013). However, as serum starvation induces autophagy and
other cellular adaptations which interfere with LD biogenesis (Rambold et al., 2015;
Shpilka et al., 2015), we chose to use LPDS starvation instead.
6.1.2 Gene perturbation studies
Loss-of-function techniques are key to obtaining information about the function of
proteins. To achieve gene/protein perturbation, we used multiple techniques, including
small interfering RNA (siRNA, I-III), gene ablation via CRISPR/Cas9 technology (II-
III), adenovirus-mediated silencing (III) and auxin-mediated degradation of proteins
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(III). All these techniques have their advantages and disadvantages and some of these
in relation to our studies are discussed here.
siRNAs are easily obtainable commercially and easy to use. However, they only allow
for transient knockdown of the gene of interest and are never 100% efficient. As they
target the mRNA of the protein of interest, it takes time to achieve protein level
depletion, and this time is dependent on the half-time of the protein. In the case of
seipin, our studies suggested that even upon depletion of a substantial amount of the
protein, the remaining seipin oligomers remain functional as LD-autonomous, LD-
growth promoting units (III). Thus, to reveal the “true” phenotype of seipin KO, i.e.
the tiny, growth abortive LDs with a few supersized ones (Salo et al., 2016; Wang et
al., 2016a), more efficient seipin removal is necessary. To this end, we utilized
CRISPR/Cas9-mediated gene ablation (Ran et al., 2013).
CRISPR-techniques (II-III) are more labor intensive and time consuming than
siRNAs, requiring cloning and often limiting dilution to obtain single clonal cell lines.
However, using CRISPR it is possible obtain cells with permanent and total disruption
of the gene of interest. In the case of seipin, the phenotype of tiny and supersized LDs
is evident in A431 seipin KO cells, recapitulating the phenotype observed in BSCL2
patient cells (II). However, CRISPR-mediated gene KO is not an acute manipulation,
and cells have ample time to adapt to the loss of the protein of interest. Thus, the
phenotypes observed in chronic KO cells may be the result of adaptations and may not
reveal the direct function of the protein of interest. To overcome this limitation, we
adapted the plant-based auxin-induced degradation system (AID) (Nishimura et al.,
2009) to examine the effects of acute seipin removal (III).
The AID system allows for rapid depletion of a protein of interest (Nishimura et al.,
2009). In this system, a degron tag is fused to a target protein and cells are genetically
engineered to exogenously express a plant-derived protein of the auxin receptor F-box
protein TIR1/AFB class. Upon addition of a molecule of the auxin class, such as
indole-3-acetic acid (IAA), these proteins form a complex which recruits the
ubiquitination machinery of the cell to the target protein, resulting in rapid
polyubiquitination and proteasomal degradation of the protein of interest (Nishimura
et al., 2009; Tan et al., 2007b). Although previously used primarily for cytosolic
proteins, we found this system also works for transmembrane proteins (Li et al.,
2019c). In study III, we used this system to characterize the phenotypes of acute seipin
removal. Of all the aforementioned techniques, AID system is by far the most
laborious, as it requires generation of homozygous knock-in clones. However, it
allows for examination of acute phenotypes.
6.1.3 Protein localization studies
A common method to decipher a protein’s function is to observe its intracellular
localization with microscopy. To facilitate this, proteins can be tagged with
fluorescent molecules or easily recognizable epitopes. In study I, we used GFP-tagged
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constructs to observe the localization of seipin and its mutants. However,
overexpression is often problematic as this typically involves a substantial
overproduction of the protein of interest, which may mask the proteins true
localization. In the case of seipin, high overexpression reveals no specific enrichment
at any ER subdomain. Thus, to obtain information about a protein’s preferred
intracellular localization, it would be optimal to examine the protein at endogenous
levels. Whilst this can sometimes be achieved via antibody staining, this technique is
highly dependent on obtaining functional antibodies for immunofluorescence and is
mainly limited to fixed cells.
To overcome these issues, we utilized several approaches. In study II, we generated
low-level overexpressing cells (using retrovirus-mediated overexpression) of GFP-
tagged WT- and A212P-seipin, which we generated on top of a seipin KO background.
This allowed for detailed characterization of the proteins’ subcellular localization,
although we were still observing circa 4-fold overexpressed levels of the protein. To
examine the localization and dynamics of seipin at endogenous levels, we utilized
CRISRP-mediated endogenous tagging via homology-directed repair (HDR) (Pinder
et al., 2015) (II-III). In this system, cells are transfected with plasmids containing Cas9
and sgRNAs targeted to loci of interest, together with a plasmid containing homology
arms flanking the targeted genomic locus and a tag of interest. After transient selection
with antibiotics and limiting dilution to obtain single clones, cell lines with
homozygous knock-in of the gene of interest with the tag of interest can be obtained.
In study II, we used this technique to tag seipin with sfGFP at its genomic locus and
image its localization in relation to LDs in both live and fixed cells.
In study III, we expanded the usage of this technique, by tagging multiple genes of
interest (seipin, ACSL3, Rab18) with various tags (SNAPf-tag, split GFPx7, degron
tag to be used with the AID system). To facilitate obtaining homozygously tagged
clones, we used fluorescence-activated cell sorting (FACS) prior to single cell cloning.
Whilst initially labor intensive, this technique is highly useful, as overexpression-
induced mislocalization artifacts can be avoided. Furthermore, these cells can be easily
further used to manipulate the subcellular localization of the protein of interest or
achieve its rapid removal on-demand with the AID system (III).
It should be noted that prior to embarking on endogenous tagging of a protein of
interest, it will be vital to know where (e.g. N- or C-terminus) the protein can be tagged
without interfering its function. Seipin appears to tolerate C-terminal tagging quite
well, with no apparent loss of function even upon tagging the protein with a split-
GFPx7 tag, which will result in a high number (up to 7) of GFP-molecules/protein.
6.1.4 Lipid biochemistry
To gain insight into the lipid levels of cells and tissues, we utilized several techniques,
such as high-performance thin layer chromatography (HPTLC) (I-III) and mass
spectrometry (III). Prior to analysis, lipids of the samples were isolated via traditional
53
solvent-based lipid extraction techniques (Bligh, E.G. and Dyer, 1959). This technique
takes advantage of the physicochemical properties of lipids and allows for their
separation into an organic phase, distinct from the water phase containing other
macromolecules, such as proteins and carbohydrates.
The distinct physicochemical properties of LDs vs other organelles also form the basis
for LD isolation techniques, which we used extensively in these studies (I, III). Lipid-
filled LDs are lighter than other cellular organelles, and after mechanical
homogenization of cell lysates they can easily be separated from other organelles via
sucrose gradient centrifugation as they end up floating to the top of the centrifuge tube
(Brasaemle and Wolins, 2006). Isolated cellular LDs can then further be subjected to
various analyses, including immunoblotting (I), imaging (III) and lipid analysis (III).
We also examined the FA flux of cells utilizing click-chemistry methods (II-III)
(Thiele et al., 2012). With this technique, we could examine the fate of an exogenously
added lipid. In our studies, we utilized alkyne-OA, which is very similar to OA, but
contains an additional triple bond at its tail. This alkyne moiety is typically not found
in biological systems but is unlikely to grossly affect the biological properties of the
lipid. After incubation of cells with alkyne-FA, lipids are extracted and a fluorogenic
“click”-reaction is performed, allowing for subsequent detection of the metabolites
using HTPLC or similar techniques. This enables examining into what lipid groups
alkyne-OA is metabolized within cells. This is akin to using radiochemically- or
isotope-labelled lipids but allows for using micromolar concentrations of the labelled
lipid and thus greatly increases specificity. In other words, when examining LD
biogenesis using alkyne-FA, there is no need to add unlabeled lipid, and thus we are
in fact tracing the entire exogenous FA pool.
6.1.5 Light microscopy
In these studies, we utilized multiple light microscopy techniques, including confocal
laser scanning microscopy (I-III), widefield imaging (II-III), Airyscan imaging (II-
III), 3D-structured illumination microscopy (3D-SIM, II) and stochastic optical
reconstruction microscopy (STORM, II). Within these modalities, we performed both
live and fixed cell imaging as well as FRAP studies. Whilst technical details are found
in the methods of the articles, a few considerations are discussed here.
In all these studies, we were imaging cellular LDs. Due to their high NL content, they
are easily stainable by organic dyes, such as Bodipy (BPY), commercial LipidTox
dyes, monodansylpentane (MDH) and the bright, BPY-derived LD540 (Spandl et al.,
2009). LDs can also be visualized by fluorescently tagged protein markers, such as the
LD coat protein perilipin-2 (Salo et al., 2016) and the ER-LD model peptides HPOS
(Kassan et al., 2013) and LiveDrop (Wang et al., 2016a), which accumulate on LDs
due to the unique physiochemical properties of the LD monolayer. Of all these probes,
we found LD540 to be superior in terms of signal-to-noise ratio and sensitivity, as it
could detect even the tiny LDs of seipin depleted cells similarly to LiveDrop or HPOS,
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but with less background. Furthermore, nascent LDs became detectable with both dyes
at roughly same time points (III). An important consideration in LD imaging is to
avoid glycerol-based mountants, as these will lead to post-fixation artifacts such as
fusion. To minimize these artifacts, we typically mounted samples in PBS or similar
water-based mountants.
The key to successful imaging is to utilize the correct technique for the question at
hand. For example, to observe quantitatively LD morphology within cell populations
and individual cells, it is not necessary to utilize the high resolution of confocal
systems and super resolution techniques, as widefield imaging gives adequate
resolution, but is more rapid, enabling higher number of cells to be sampled for
quantitative analysis. On the other hand, minute details such as estimates of the seipin
oligomer size in the ER could only be approached with super resolution techniques
such as STORM.
For live cell imaging, the main consideration is to obtain sufficient signal for analysis
but without causing phototoxicity or bleaching. When imaging low-abundance
objects, such as endogenously tagged proteins, an important aspect to consider is the
“photon budget” and how to spend it. Microscopy settings (such as laser intensity,
detector gain, times between acquisitions in a time series etc.) have to be set
accordingly so that adequate data can be obtained to answer the question at hand. Thus,
to examine a rapid (seconds timescale) process such as nascent LD formation in the
dynamic ER network or rapid LD motility, acquisition rates of 1 frame/second and
less have to be used. On the other hand, to observe slower processes (minutes-hours
time scales), such as LD size changes over time, imaging at such high frame rates for
prolonged periods of time would result in phototoxicity and bleaching, hampering
detailed analysis.
It is also essential to optimize all possible parameters, since the actual biological
events (such as LD biogenesis) cannot easily be speeded up or slowed down according
to your needs. These optimizable parameters include using appropriate phenol-red free
imaging medium, anti-fade reagents and, most importantly, bright and photostable
dyes and fluorescent proteins. To this end, we moved from traditional eGFP to using
tags such as split7x-GFP (Kamiyama et al., 2016) (which allows multiple copies of
sfGFP to tag one molecule) and SNAPf (Sun et al., 2011) (which allows to label
proteins with bright organic dyes). In studies II-III we performed the majority of live
cell imaging using a Zeiss Airyscan system, which due to its unique detector
architecture allows for higher resolution and, most importantly, higher sensitivity than
traditional confocal microscopes (Korobchevskaya et al., 2017). It should be noted,
however, that we did not have access to spinning disk microscopes or advanced
modalities like lattice light sheet imaging during these studies. It would be highly
interesting to use these techniques for imaging of nascent LD biogenesis.
In studies II-III, we used FRAP techniques to address molecule motility in cells. In
this technique, a portion of fluorescently labelled molecules are bleached and
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fluorescence recovery to that bleached region of interest is followed over time. As
bleaching of common fluorophores is essentially irreversible, recovery then gives an
indication of molecule mobility (Lippincott-Schwartz et al., 2001). To trace ER-to-LD
protein trafficking we bleached HPOS-mCherry signal within individual LDs and LD
clusters and followed recovery of the fluorescence (II). Since LDs are motile
organelles, we simultaneously imaged an additional LD marker, a LipidTox dye, to
ensure that we could trace fluorescence recovery to the bleached LD, even if that
moved during time lapse image acquisition. Using this technique, we found HPOS
recovery to LDs to be impaired in seipin KO cells, whilst HPOS recovery in the ER
was unchanged, suggesting impaired ER-to-LD trafficking (II).
We also performed BPY-C12 FRAP in LDs (II-III). BPY-C12 is a commonly used
fluorescent FA analog and can thus be thought to trace lipid trafficking within the cell
(Ohsaki et al., 2016; Rambold et al., 2015; Salo et al., 2016). In line with this, we and
others have found that it is metabolized in cells and can also be esterified. However, a
major issue in this technique is that for each observable fluorophore, we have no way
of knowing in what kind of lipid it is. Thus, whilst we found that a majority of BPY-
C12 appeared to be as esterified NL molecules in isolated cellular LDs, it doesn’t
directly indicate we are observing NL trafficking when performing BPY-C12 FRAP.
Furthermore, the BPY side chain is likely a major contributor to BPY-C12’s
intracellular behavior, and thus kinetic parameters obtained with FRAP cannot be
considered as direct indicators of NL trafficking. Further developments in fluorescent
lipid dyes are necessary to overcome this limitation.
For image analysis, we performed multiple different analyses, including co-
localization studies (I-II), feature-based image analysis (II-III), FRAP analysis and
tracking of objects and their intensities (II-III). These were performed using software
such as Image J FIJI, Huygens, Matlab, CellProfiler, Ilastik and ICY. We aimed to
automate as much of the analysis as possible to speed up the work flow and to avoid
unintentional bias. For example, for analysis of LD size distributions and localizations
in cells, extensive automated workflows were developed to analyze hundreds-
thousands of cells automatically. For more difficult tasks, such as tracking of objects,
we were partially forced to rely on manual tracking of objects to ascertain reliable
tracking results.
In image analysis, an important consideration is how to develop a workflow where the
data (images) are analyzed accurately, but without having to make “judgement calls”
during the analysis, to ensure unbiased results. Automation, scripting and blinding are
excellent tools to facilitate this. For example, for LD motility analysis in study II, we
used two parallel approaches. We manually quantified the motility of dozens of
droplets, which was labor-intensive, but accurate. We additionally used co-
localization analysis of adjacent time frames to measure a similar parameter, but for a
much larger number of objects, with the idea that the less overlap between subsequent
frames, the more the objects had moved. As both techniques gave matching results
regarding the general phenotype (i.e. LDs moved more rapidly in seipin KO cells than
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in WT cells), we could use the automated, more rapid technique for similar analyses
in many different conditions.
An important aspect of the image analysis techniques we used in studies II-III was the
detailed analysis of LD size distributions on a single-cell level. Using automated
scripts developed for detecting single LDs in cells, we could assess the effects of acute
seipin removal on the size distributions of cellular LDs. Whilst overall LD coverage
of cell areas was not dramatically affected, the size heterogeneity of small and large
LDs became apparent. This indicates complex regulation of LD sizes and suggests that
single averaged parameters, such as total LD numbers/cell or mean LD sizes/cell,
which are typically used for this kind of analyses in the literature, are not necessarily
sufficient to completely describe the phenotypes observed.
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7 RESULTS AND DISCUSSION
7.1 ALLEVIATION OF SEIPINOPATHY RELATED ER
STRESS BY TRIGLYCERIDE STORAGE (I)
Mutations in the luminal N-glycosylation site of seipin (N88S, S90L) lead to a
dominantly inherited form of motor neuron disease, a form of spastic paraplegia
(SPG17 or Silver syndrome), termed collectively as “seipinopathies” (Ito and Suzuki,
2009). Previous work had suggested the pathogenesis of seipinopathy to involve
aggregation of misfolded seipin mutants, leading concomitant ER stress activation (Ito
and Suzuki, 2007; Yagi et al., 2011). However, in HeLa cells N88S-seipin aggregates
were in fact found to be protective against ER stress (Ito et al., 2012), although the
detailed nature of these cytoplasmic inclusions remained unclear. Importantly,
previous work had not explored links between NL metabolism and seipinopathy
causing seipin mutants.
7.1.1 N88S-Seipin localizes to LDs
In this study we set out to investigate the subcellular localization of N88S-seipin and
its effects on lipid status of cells of CNS origin (human astrocytoma U251 MG cells
and murine NSC-34 motor neuron-like cells). We ectopically expressed GFP-tagged
WT- and N88S-seipin proteins and found that overexpression of the mutant protein
decreased the TAG content of cells, whilst WT-seipin overexpression had no effect (I,
Fig. 1). siRNA-mediated knockdown of seipin also lead to decreased TAG storage (I,
Fig. S1), suggesting N88S-seipin asserts a dominant negative effect on the lipid status
of the cells. WT-seipin was localized to the ER, whilst in a high fraction of cells,
N88S-seipin formed distinct, often ring-like inclusions (I, Fig. 2). Co-staining with
lipophilic dyes revealed these inclusions to be LDs, and the segregation of N88S-
seipin from bulk ER to LDs could be increased via OA treatment of cells (I, Fig. 2-3).
Using biochemically isolated LDs from cells, we found a higher fraction of N88S-
seipin than WT-seipin copurifying with LDs (I, Fig. 3). These data suggest that N88S-
seipin, in contrast to WT-seipin, readily accumulates at LDs or ER regions juxtaposed
to LDs and this segregation can be increased by LD induction.
7.1.2 Alleviation of N88S-seipin and tunicamycin induced ER stress by
triglyceride storage
In agreement with previous reports in non-neurogenic cell models (Ito and Suzuki,
2007), we found that N88S-seipin overexpression lead to increased ER stress also in
neuronal cells (I, Fig. 3). We measured ER stress by immunoblotting
of CCAAT/enhancer binding protein (CHOP), a commonly used ER stress marker
(Hetz, 2012). CHOP levels were also increased by treatment of cells with the ER-
stressor tunicamycin, a general inhibitor of N-glycosylation, which leads to
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accumulation of misfolded proteins in the ER (I, Fig. 4). Importantly, ER stress levels
induced by both N88S-seipin and tunicamycin could be alleviated by increasing LD
abundance, either via OA treatment or ATGL knockdown (I, Fig 3-4, S2). These
results suggest that increasing TAG storage at LDs may protect neuronal cells from
ER stress induced by protein misfolding.
7.1.3 Zebrafish model of seipinopathy
Finally, we utilized zebrafish, a common model system in lipid metabolism studies
(Hölttä-Vuori et al., 2010), to generate an in vivo model for seipinopathy. We induced
human WT or N88S-seipin overexpression by mRNA microinjection at a two-cell
stage and characterized the ensuing phenotypes during the first days post fertilization
(dpf). We found that N88S- but not WT-seipin overexpression induced lipid
abnormalities in the developing zebrafish (I, Fig. 5). A marked reduction of TAG
levels in 2-4 dpf zebrafish heads was observed, with a concomitant increase in TAG
levels in the trunks of the larvae, suggesting defective yolk lipid mobilization to the
developing brain (I, Fig. 5, S3). This was accompanied by a decrease in free
swimming of the N88S-expressing zebrafish larvae at 4-6 dpf, without obvious
morphological abnormalities or loss of motor neurons (I, Fig. 5, S3-S4). This defect
could be rescued by supplementation with exogenous OA, which also decreased
CHOP levels in the developing zebrafish (I, Fig 5). These results suggest that N88S-
seipin expression can modulate lipid levels and motor neuron function also in vivo.
7.1.4 LDs and ER stress
In this study, we found that overexpression of N88S-seipin decreases cellular and
nervous tissue TAG content. Restoration of defective TAG storage lead to reduced ER
stress and improved the motility defect caused by N88S-seipin. We propose that
increase in LDs is protective against ER stress, possibly via sequestration of misfolded
proteins, such as N88S-seipin, to LDs or LD-associated ER subdomains. Increasing
LD content has since been found to be protective against ER stress in several other
studies (Bosma et al., 2014; Qiu et al., 2016). In one study, ATGL knockout mouse
livers were robustly protected against tunicamycin induced ER stress (Fuchs et al.,
2012). However, in those studies the protective effect of increased LDs against ER
stress was mostly attributed to sequestration of toxic lipid metabolites within the LDs.
Whilst it is clear that the monounsaturated OA is beneficial for membrane
homeostasis, especially in combating saturated FA induced lipotoxicity (for a recent
review, see (Palomer et al., 2018)), we postulate additionally that the presence of LDs
as such may be protective. More specifically, LDs may offer large hydrophobic
surfaces that help to reduce the concentration of misfolded proteins in the ER and
prevent their toxic ER aggregation, as exemplified by the N88S mutant (see below for
details). In line with this, a recent study found LDs to be necessary for inclusion body
clearance in a yeast model of proteotoxicity (Moldavski et al., 2015).
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Besides providing mechanistic insight into seipinopathy and ER stress, our study also
suggested a link between motor neuron disease and NL storage, a notion strengthened
in the past years (Pennetta and Welte, 2018). In particular, also other proteins whose
mutations lead to inherited forms of spastic paraplegias, have extensively been linked
to LD metabolism (Blackstone, 2018; Eastman et al., 2009; Klemm et al., 2013;
Papadopoulos et al., 2015; Renvoisé et al., 2016). Indeed, it can be envisioned that
cells with an intrinsically low NL content, such as neuronal cells, are particularly
vulnerable to perturbations of LD assembly and functions. Remarkably, a treatment
regime including PUFAs has recently been shown to alleviate neurological symptoms
of a patient suffering from the devastating seipin-related Celia’s encephalopathy
(Araújo-Vilar et al., 2018).
An interesting, thus far unresolved question raised in this study is the detailed
localization of N88S-seipin in relation to LDs. Whilst our immunofluorescence
imaging clearly demonstrates N88S-seipin aggregates juxtaposed to LDs, due to the
large luminal domains of seipin it seems unlikely that this protein could escape the ER
bilayer and be accommodated on the LD monolayer. Rather, it may be that N88S
mutation compromises seipin oligomer assembly in such a way that larger patches of
the ER are in close proximity to the LD. Indeed, perhaps these LDs are partially
embedded in the ER, as has been proposed for NL-lipoprotein accumulations in the
ER induced by misfolded ApoB (Morishita et al., 2019; Ohsaki et al., 2008). How
N88S-seipin may affect the seipin-mediated ER-LD neck structure, as described in
detail in study III, awaits further characterization and would require EM studies of
ER-LD necks in N88S-seipin expressing cells.
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7.2 SEIPIN REGULATES ER-LD CONTACTS AND CARGO
DELIVERY (II)
Loss-of-function mutations in seipin lead to BSCL2, the most severe form of
lipodystrophy in humans, characterized by near complete lack of adipose tissue
(Magré et al., 2001). Seipin appears to play a critical, yet poorly understood, role in
LD biogenesis, as its disturbance results in morphologically aberrant LDs in a wide
variety of model systems (Chen and Goodman, 2017). Work in yeast has suggested
that seipin localizes to ER-LD contacts, wherein it may modulate LD protein and/or
lipid composition (Cartwright et al., 2015; Fei et al., 2008; Grippa et al., 2015;
Szymanski et al., 2007; Wang et al., 2014). In this study, we sought to investigate the
function of seipin in LD formation in human cells, utilizing both metabolically active
and genetically malleable human epidermoid carcinoma cells (A431) as wells as
control and BSCL2 patient fibroblasts.
7.2.1 Aberrant LD biogenesis in seipin knockout cells
We first knocked out seipin from A431 cells using CRISPR/Cas9 technology and
characterized the LD phenotype. As we were interested in the earliest defects of LD
assembly, we first depleted cells of pre-existing LDs and then added OA to cells for
short periods of time. We observed that de novo generated LDs in seipin knockout
(SKO) cells were more numerous and heterogeneous in size, with some supersized
LDs and a massive accumulation of tiny LDs (II, Fig. 1A-B). By EM, these tiny LDs
were in the size range of circa 100-200 nm in diameter, and live cell imaging revealed
they displayed highly increased motility and aberrant, multidirectional trajectories (II,
Fig. 2). Tiny LDs were also observed upon longer OA incubations in SKO A431 cells
and were readily detectable in BSCL2 patient fibroblasts (II, Fig. 6-7). The LD
phenotype could be rescued by re-introduction of GFP-tagged WT-seipin to the cells,
whilst a BSCL2-causing point mutant, A212P-seipin, failed to do so (II, Fig. 1A-B).
7.2.2 Seipin is stably localized at ER-LD contacts
We next investigated the subcellular localization of WT- and A212P-seipin. Both
proteins formed discrete puncta in the ER network, likely representing individual
seipin oligomers (II, Fig. 1C). The oligomers formed by A212P appeared smaller in
size as assessed by super resolution STORM imaging, in agreement with previous in
vitro work (II, Fig. 1D) (Binns et al., 2010; Sim et al., 2013). WT-seipin foci were
found to be enriched at ER-LD contacts, with typically one such foci per LD, whilst
A212P-seipin was not enriched at ER-LD contacts, arguing for the functional
relevance of this location (II Fig. 1C-G). The associations of WT-seipin with LDs
was found to be stable, with seipin foci hovering around the LDs or moving together
with them (II, Fig 2A). We also examined endogenous seipin localization by tagging
the protein chromosomally with sfGFP and found a similar localization pattern of
stable ER-LD contact enrichment (II, Fig. 1H, EV2). As a TM ER protein, seipin
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cannot escape the ER and these data thus reveal that LDs exhibit a close physical
relationship with the ER, with seipin stably localizing at the ER–LD junctions.
A similar localization at ER-LD contacts had previously been reported for the yeast
seipin complex (Fei et al., 2008; Grippa et al., 2015; Szymanski et al., 2007). However,
previous studies in mammalian systems had failed to detect ER-LD contact
enrichment of seipin (Fei et al., 2011b; Hölttä-Vuori et al., 2013; Payne et al., 2008;
Sim et al., 2012; Talukder et al., 2015; Tian et al., 2011; Yang et al., 2013), likely due
to the use of protein overexpression in those studies. These data exemplify the
importance of investigating protein subcellular localization at physiological
expression levels.
7.2.3 Seipin regulates ER-LD contact morphology
The stable localization of seipin at ER-LD contacts prompted us to examine the
association of SKO LDs with the ER. Using 3D-EM and live cell Airyscan imaging,
we found that whilst WT LDs were always in contact with the ER and moving along
ER elements, a subset of the tiny, fast-moving LDs in SKO cells were completely
detached from the ER (II, Fig 2). We also assessed the detailed morphology of ER-
LD contacts in WT and SKO cells by electron tomography. WT ER-LD contacts were
often regular in appearance, with a foot-like ER process that touched the LD (II, Fig
3). 3D modeling revealed several discrete patch-like ER contacts per LD. In SKO
cells, however, some LDs displayed no ER contacts or only narrow string-like bridges
to the ER, whilst others had very extensive ER contacts, with modelling showing a
web-like ER attachment (II, Fig 3). Together, these data suggest that seipin controls
the extent of ER–LD contacts, as seipin loss is accompanied by missing, rudimentary,
or very large ER–LD contacts. LDs without ER connections were also observed in
BSCL2 patient fibroblasts, but not in control fibroblasts.
7.2.4 Seipin regulates ER-LD protein and lipid trafficking
We next assessed the consequences of abnormal ER-LD connectivity by examining
protein and lipid cargo recruitment from the ER to LDs. The trafficking of ACSL3, a
key acyltransferase implicated in early LD assembly (Kassan et al., 2013), from ER to
LDs was disrupted in SKO cells and BSCL2 patient cells (II, Fig. 4, 7F-G). Whilst
all WT LDs displayed enrichment of this class I LD protein, in SKO cells ACSL3
accumulated at ER-LD junctions instead. Using heterologous cells fusions, we found
that for efficient ACSL3 transfer to the LD monolayer, seipin needs to be present
during LD formation, as reintroducing seipin to SKO cells with pre-existing LDs
failed to facilitate ACSL3 LD recruitment (II, Fig. 4C). In contrast, exogenously
expressed perilipin-2, a class II LD protein which targets to LDs from the cytoplasm
(Brasaemle et al., 1997), displayed no targeting defects in SKO cells (II, Fig. 4, EV4).
Also HPOS, a model ER-LD peptide employing the LD-targeting sequence of
caveolin-1 (Kassan et al., 2013), could initially reach virtually all WT and SKO LDs
(II, Fig. 5, EV5). However, FRAP studies revealed that subsequent trafficking of this
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model peptide from the ER to LDs was substantially hampered in SKO cells. In WT
cells, FRAP suggested bidirectional, continuous transfer of HPOS between the ER and
LDs, but in SKO cells trafficking to pre-existing LDs was compromised (II, Fig. 5A-
B). Together, these data suggest that trafficking of protein cargo from the ER to LDs
is impaired in SKO cells.
To probe the lipid transport capabilities of ER–LD junctions, we utilized BPY-C12, a
fluorescent FA analog used to monitor cellular FA trafficking in cells (Ohsaki et al.,
2016; Rambold et al., 2015), which we found could be esterified to NLs and stored in
LDs (II, Fig EV6). FRAP experiments and longer time lapse imaging suggested WT
cells could continuously transport NL cargo to LDs, whilst this transport was hindered
in SKO cells (II, Fig 5D-H). Metabolic labeling experiments with alkyne-labelled FA
and click chemistry showed no difference in initial FA flux between WT and SKO
cells during the earliest stages of LD formation (II, Fig 6H). However, in cells with
pre-existing LDs, FA incorporation into NLs was impaired in SKO cells and BSCL2
patient fibroblasts (II, Fig 5H, 7H). Overall, in seipin deficient cells initial protein and
lipid trafficking to nascent LDs is at least partly preserved and NL synthesis during
early LD assembly is intact, but subsequent trafficking of cargo between ER and more
mature LDs is compromised, and this is accompanied by decreased net NL synthesis.
Finally, we examined LDs of cells after longer periods of FA incubation, probing LD
motility, ER-LD proximity and protein exchange between ER and LDs (II, Fig 6). We
found that the connectivity of LDs to the ER is continuous over time in WT cells,
whilst in the absence of seipin, tiny “nascent-like” LDs with dysfunctional and missing
ER contacts are continuously present. Over time, in SKO cells, some LDs become
strikingly supersized, and these LDs displayed heterogeneous ER connectivity, with
some showing no recovery of the HPOS peptide in FRAP experiments, whilst in others
the recovery was accelerated, suggesting more efficient/more numerous ER-LD
contacts, or unrestrained transport.
7.2.5 Seipin and ER-LD contacts
Overall, in this study we described a role for seipin in ensuring functional ER–LD
contacts of LDs in human cells (II, Fig. 8). In the absence of seipin, cells accumulated
high numbers of tiny LDs, which failed to grow. These data may suggest that the initial
formation of LDs in the ER does not depend on seipin, but in the absence of seipin,
growth of most LDs beyond a size of circa 100-200 nm becomes abortive. Similar
results were obtained in another study at the same time, employing primarily
Drosophila cells, where the authors suggested seipin is required for converting nascent
LDs to more mature ones (Wang et al., 2016a). However, our data suggested that
seipin may instead be required for the very earliest steps of LD assembly, as adding
back seipin via heterologous cell fusions failed to rescue ACSL3 recruitment to LDs
initially formed in the absence of seipin. Indeed, assessing what role, if any, seipin
plays in LD maintenance after LD formation is hindered by the fact that the early steps
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of LD biogenesis are so severely compromised in the absence of seipin. This question
we subsequently tackled in our follow-up study (III).
Based on our data, we propose seipin may structurally contribute to ER-LD junctions
by stabilizing them. Indeed, we found more heterogeneous ER-LD contacts in its
absence together with impaired ER-LD junction functionality. Morphologically
aberrant ER-LD contacts in the absence of seipin have been observed by EM also in
seipin mutant yeast cells (Grippa et al., 2015; Romanauska and Köhler, 2018;
Wolinski et al., 2015). However, our data analysis was hampered by the fact that also
WT LDs often contained more than one zone of ER-LD proximity in ET stacks, whilst
seipin was most often present as only a single foci/LD. Thus, LDs likely have multiple
different types of connections with the ER, of which only a subset may be regulated
by seipin. Other regulators of ER-LD contacts include Rab18 (Ozeki et al., 2005; Xu
et al., 2018), FITM2 (Choudhary et al., 2015), DGAT2-FATP2 (Xu et al., 2012) and
Snx14 (Datta et al., 2019). Pinpointing the morphology and functionality of seipin-
mediated ER-LD contacts was the topic study III.
The most striking finding of this study was the realization that at least in the
mammalian cell types under study, virtually all LDs of WT cells appeared to be
connected to the ER membrane. Similar findings had been reported in yeast model
systems (Jacquier et al., 2011), but in mammalian cells it was commonly presumed
that most LDs would detach from the ER after their initial biogenesis (Pol et al., 2014).
Indeed, in single section EM images LDs can often be found to exist in isolation in the
cytosol. However, when systematically assessing ER-LD proximity using 3D-EM and
live cell imaging, all LDs in WT cells appeared to be in the proximity of the ER.
Motility of LDs is also thought to indicate detachment from the ER (Pol et al., 2014),
but we found LDs to be motile along ER profiles, suggesting on-going connectivity
with the ER. Finally, our FRAP studies revealed on-going lipid and protein cargo
exchange between LDs and the ER. These processes were seipin-mediated,
demonstrating that seipin is important in maintaining ER-LD contacts. This is best
exemplified by the fact that in the absence of seipin some LDs were completely
detached from ER membranes. However, as most LDs were still proximal to the ER
even in the absence of seipin, but failed to adequately grow, seipin’s role is not limited
to acting as an ER-LD tether, but it likely controls ER-LD junction functions in a more
intricate manner.
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7.3 SEIPIN FACILITATES TRIGLYCERIDE FLOW TO
LIPID DROPLET AND COUNTERACTS DROPLET
RIPENING VIA ENDOPLASMIC RETICULUM
CONTACT (III)
Work from numerous model systems has shown that LD biogenesis is severely
hampered in the absence of the ER-LD contact protein seipin (Chen and Goodman,
2017), with a phenotype of numerous tiny LDs and a few supersized LDs, without
robust changes in cellular lipid profiles (Salo et al., 2016; Wang et al., 2016a). LD
growth arises via TAG transfer from the ER to LDs, via localized TAG generation at
the LD surface or via TAG transfer between LDs (Walther et al., 2017). Biophysically,
LDs are  oil-in-water emulsion droplets expected to undergo spontaneous
destabilization processes (Thiam et al., 2013a), such as fusion and ripening, which, if
left unrestricted, would lead to the development of supersized LDs (Thiam and Beller,
2017). However, cells have developed protein machineries to regulate LD growth, and
seipin is likely a key player in this regulation. In this study we continued our
investigation of seipin in mammalian A431 cells, using techniques to manipulate
seipin subcellular localization and rapidly deplete it from ER-LD contacts, to uncover
the role of seipin in ER-LD contact maintenance.
7.3.1 Seipin can determine the site of LD formation
In mammalian cells, seipin exists as discrete, motile ER-associated foci, a subset of
which associate with LDs (Salo et al., 2016; Wang et al., 2016a). Previous work
suggested that seipin associates with budded out LDs, and upon encountering such a
nascent LDs, enables its growth (Wang et al., 2016a). Using live cell super-resolution
imaging in cells where seipin is chromosomally tagged with bright fluorophores, we
found LD-destined seipin foci to be immobilized prior to accumulation of well-known
nascent LD markers (III, Fig. 1A-H). Indeed, correlative light and electron
microscopy (CLEM) tomography of cells first stringently delipidated and then treated
with OA for short periods of time revealed small LD-like structures circa 30-100 nm
in diameter at sites marked by seipin (III, Fig. 1I-J). These data challenge the previous
view that seipin associates with preformed nascent LDs (Wang et al., 2016a), and
suggest that seipin may determine where an LD starts to develop. Interestingly, live
cell imaging of LD biogenesis also revealed that nascent LDs typically form at ER
structures around the cell in a highly dispersed manner, with distances between newly
forming LDs higher than expected by chance (III, Fig. 1C). In other words, a growing
LD appeared to inhibit new LDs from forming in its vicinity.
To test whether seipin may define a subdomain of the ER that is destined for LD
formation, we artificially targeted seipin to the nuclear envelope (NE), a subdomain
of the ER. To achieve this, we employed GFP-nanobody, a peptide which binds to
GFP in cells with high affinity (Rothbauer et al., 2006), and the intrinsic interaction
of KASH2 and SUN2 at the NE (Sosa et al., 2012). We fused GFP-nanobody to the
65
SUN2-interacting fragment of KASH2, and co-expressed this GFP-nanobody-KASH
fusion protein and SUN2 in cells with endogenously GFP-tagged seipin (III, Fig. 2A).
Using this system, we could restrict most endogenous seipin to localize exclusively at
the cytoplasmic leaflet of the NE (III, Fig. 2B). In these seipin NE-trapped cells, the
vast majority of LDs now formed at the NE, in contrast to the dispersed manner
observed in control cells (III, Fig. 2C-D). Thus, seipin can determine the site of LD
formation.
7.3.2 Architecture of seipin-mediated ER-LD contacts
We next assessed the ultrastructure of seipin-mediated membrane-LD contact sites by
ET and CLEM. LDs in A431 cells typically harbor only a single seipin foci, but
multiple proximities with the ER, reflecting heterogeneity in ER-LD contact
machinery and function (Salo and Ikonen, 2019; Salo et al., 2016). The uniform
architecture of the NE, as compared to the rest of the ER, enabled us to more accurately
investigate the structure of seipin-mediated membrane-LD contacts in the seipin NE-
trapped cells. We found the NE-trapped LDs to exhibit typically 1-2 clear NE contacts,
with a strikingly uniform appearance and dimensions (III, Fig. 2E-F). At these circa
15 nm-in-diameter neck-like contacts, a small fraction of the LD monolayer appeared
to be in direct contact with the ER lumen. Similar necks could be seen by CLEM at
seipin sites of cells without NE-trapping of seipin, and in WT A431 cells and primary
human fibroblasts (III, Fig. 2G, S2). Finally, their appearance could be disrupted via
acute removal of seipin (see below) (III, Fig. S2). Together, these data suggest that
seipin-mediated ER-LD membrane contacts display a uniform neck-like architecture.
The architecture of the seipin-mediated ER-LD contact sites fit well with the structural
insights into the seipin oligomer (Sui et al., 2018; Yan et al., 2018). Indeed, the cryo-
EM structures of the luminal domains of human and Drosophila seipin oligomers
revealed a 15- to 20-nm-wide ring-shaped structure intercalating into the bilayer of
the ER (Sui et al., 2018; Yan et al., 2018), which is well in-line with our measurements
of the ER-LD necks. Moreover, Sui et al found that the luminal domain of seipin
contains a hydrophobic helix which showed high affinity for a NL covered monolayer.
Together with our findings, these data suggest that nm-sized NL lenses in the ER may
be detected and stabilized by seipin oligomers, thus marking the site where LDs start
to develop. Seipin may itself restrict the budding size of forming LDs and perhaps
stabilize the high local curvature of the ER-LD neck, as previously proposed (Han et
al., 2015). Interestingly, an ER-LD neck with very similar dimensions (circa 15 nm
diameter with apparent contact of the ER lumen with the LD monolayer), was recently
observed in a HeLa cell using in situ cryo-ET (Mahamid et al., 2019).
7.3.3 Acute depletion of seipin via auxin-induced degradation
We next investigated the functionality of seipin-mediated ER-LD contacts. We had
previously described defective cargo transfer between the ER and LDs in the absence
of seipin (II), but these could relate to secondary effects due to aberrancies in earliest
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steps of LD assembly. Thus, to investigate the function of seipin at pre-existing ER-
LD contacts we generated cells in which endogenously tagged seipin could be acutely
depleted by adapting the AID-system (Nishimura et al., 2009) (III, Fig. 3A). In these
seipin degron cells, seipin could be rapidly and efficiently (>95% reduction of seipin
protein in 30 min) depleted via addition of the degradation inducer IAA (III, Fig. 3B).
Importantly, using this system seipin could also be rapidly depleted from pre-existing
ER-LD contacts (III, Fig. 3C). Depletion of seipin prior to LD biogenesis resulted in
the familiar phenotype of small and supersized LDs (III, Fig. 3D), common for SKO
cells (Salo et al., 2016; Wang et al., 2016a), validating the system for studying the
effects of acute seipin depletion.
7.3.4 Ripening-mediated heterogenous growth of LDs upon acute seipin
removal
Using seipin degron cells, we assessed the effects of acute seipin removal on the
growth of pre-existing LDs. Upon acute seipin removal, larger LDs began to grow
faster, whilst smaller nearby LDs started to shrink, giving rise to the seipin phenotype
of small and supersized LDs within a few hours (III, Fig 3E, 4A-B). These changes
appeared to be due to defective aliquoting of lipids between the ER and LDs, as they
occurred even in the presence of DGAT2 inhibition, lipolysis inhibition or
concomitant inhibition of both de novo lipogenesis and lipolysis (III, Fig. 4E, S3-S5).
Importantly, despite clear changes in LD size distributions, we could not detect
differences in net lipolysis, overall FA flux or the lipidomic profiles of LDs (III, Fig.
4C-D, S3B). Finally, FRAP studies utilizing BPY-C12 strengthened the notion that
upon acute seipin removal, larger LDs started to gain relatively more NLs from the
ER, whilst smaller LDs did not (III, Fig. 4F-I, S5E-H). In control cells both small and
larger LDs gained NLs in a similar manner. These data demonstrate that seipin is
required for LD size maintenance and homogenous growth also after initial LD
biogenesis.
These LD size alterations were reminiscent of what had been previously observed for
LD-LD lipid transfer mediated by FSP-27/CIDE-C, i.e. they occurred according to the
principles of ripening, with larger LDs gaining content at the expense of smaller LDs
(Gong et al., 2011). However, the inhomogeneous growth of LDs upon acute seipin
removal was not dependent on direct LD-LD contacts (III, Fig. 4F) and CIDE family
proteins are not detectable at LDs of A431 cells (Moessinger et al., 2011). As NL
transport through the aqueous cytosol is likely to be extremely slow, we thus
postulated that this ripening process may occur through the connecting lipid phase, i.e.
the ER. Indeed, utilizing a previously described in vitro system with artificial LDs
connected to flattened giant unilamellar vesicles (GUVs) (Ben M’barek et al., 2017),
we could demonstrate ripening-mediated growth and shrinkage of artificial LDs
through the connecting bilayer (III, Fig. 5, S5). In this system, growth and shrinkage
of LDs was absolutely dependent on their connection with the bilayer, as LDs not in
contact with the bilayer did not change in size (III, Fig. 5K-N).
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Our data thus far suggested that seipin may help to prevent ripening-induced changes
of LDs, and acute removal of seipin revealed a principle of LD ripening via the ER.
To test this more directly, we combined isolated cellular LDs +/- fluorescently tagged
seipin with flattened GUV bilayers and performed time lapse imaging of LD size
changes (III, Fig 6A). In this setup, similar to artificial LDs, also cellular membrane-
connected LDs experienced ripening-mediated LD size changes, with smaller LDs
shrinking and larger LDs growing. At the same time, LDs not on the membrane did
not change in size, as expected (III, Fig. 6B-C). Importantly, upon analyzing
membrane-associated LDs, we found that seipin containing LDs shrunk less or grew
more than similar sized LDs devoid of seipin (III, Fig. 6D-E, S7B-C).  This suggests
that seipin can facilitate LD growth and prevent ripening-induced shrinkage of small
LDs in vitro.
7.3.1 Seipin at the ER-LD neck facilitates continuous NL transfer to the LD
We next analyzed the growth promoting function of seipin at ER-LD contacts in detail
in cells. By limiting the number of seipin foci either globally via partial knockdown
or locally via NE-trapping, we found that seipin promotes LD growth LD-
autonomously in cells. In cells with few remaining seipins, these were invariably
enriched at ER-LD contacts and the seipin-associated LDs grew more rapidly than
LDs in cells with higher seipin content (III, Fig. 7A-C). Similarly, in the periphery of
seipin NE-trapped cells, where local seipin density was low, seipin associated LDs
grew faster than in the NE, where seipin content was high (III, Fig. 7D-F). These data
suggest that seipin promotes the growth of the LD it is associated with. Furthermore,
the growth of a LD appears to inhibit the growth rate of other nearby LDs. Finally, we
performed competition experiments in cells, where via cell-fusions we could
simultaneously examine the size changes of LDs which still harbored seipin at their
ER contact and LDs where seipin had been acutely depleted. In line with our in vitro
results, LDs containing seipin grew, whilst LDs where seipin had been depleted,
shrunk in size (III, Fig. 7G-H).
Overall, the findings in this study suggest that seipin is critical for LD growth by
partitioning TAG from the ER to LDs. Upon acute seipin removal, a principle of LD
ripening via the ER becomes apparent, with larger LDs acquiring NL at the expense
of smaller ones via the connecting lipid phase, the ER (III, Fig. 7J). At the ER-LD
neck, seipin may thus actively transfer NLs to the LD or modulate the structure of the
contact site to enable such transfer. Whilst the molecular mechanism behind this
phenomenon is still unclear, our data together with recent structural insights into seipin
complex (Sui et al., 2018; Yan et al., 2018), and the uniform membrane architecture
of ER-LD necks raise the possibility that seipin restricts the diameter of the LD neck
and controls lipid diffusion at this site.
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7.3.2 Seipin as an organizer of NL flux at the ER-LD network
The notion that LDs may grow via ripening through the ER is a new concept, which
will require further investigation in the future. Whilst ripening-mediated growth
through the connecting phase is a clearly observable phenomenon in vitro, cells have
developed machinery, such as seipin, to counteract it. Upon LD biogenesis in the
absence of seipin, some LDs become supersized, likely due to ripening-mediated
growth via the ER, whilst other LDs fail to do so, as they may have already detached
from the ER (II). Upon seipin removal from pre-existing LDs, all LDs become
susceptible to ripening, as they are in contact with the ER. However, the LD size
changes we observed were most obvious in conditions of sustained LD growth, i.e.
with new TAG generation in the ER, suggesting that even upon seipin removal, the
rate of TAG backflow from LDs to the ER is likely to be quite low. Thus, our data
generally favor a model wherein seipin promotes NL deposition to the LDs, rather
than prevents it backflow. It is intriguing to speculate that the role of seipin is thus
most important for smaller LDs to grow, as they have to “fight against” the ripening-
mediated tendency to shrink.
In our study, we could not find defects in overall cellular lipid metabolism or FA flux
upon acute seipin removal, suggesting seipin’s primary role may not be related to
control of enzymatic activities or lipolysis, as has been suggested (Boutet et al., 2009;
Chen et al., 2012; Pagac et al., 2016; Talukder et al., 2015). However, our data cannot
rule out a more localized defect in for example PA handling or desaturase activities.
Furthermore, we could not detect changes in the lipidomes of isolated LDs upon acute
seipin removal. This could be thought as evidence against a role for seipin in
regulating LD monolayer properties (Grippa et al., 2015). However, we only analyzed
bulk LD preparations, and thus whether the tiny (shrinking or detached) LDs would
show an altered lipid profile vs the larger (aberrantly growing) LDs is not known.
Regulated growth of LDs via the ER is likely also crucial for adipogenesis, as in
BSCL2 knockout preadipocytes, LD heterogeneity preceded their eventual
disappearance and defective adipogenesis (Chen et al., 2012). Furthermore, whilst
uncontrolled ripening would eventually be presumed to lead to supersized unilocular
LDs, the hallmark of mature adipocytes, this is not a spontaneous process as proper
adipogenesis requires both seipins and CIDE proteins (Chen et al., 2009; Slayton et
al., 2019). In this scenario, seipin facilitates growth of LDs via the ER, whilst CIDE
proteins promote their coalescence. Also in a recent yeast study, loss of seipin function
and overexpression of exogenous CIDE-A had similar effects on droplet morphology,
suggesting they work in the same pathway, but with antagonistic roles (Lv et al.,
2018).
Our findings further strengthen the notion that seipin may define a subdomain of the
ER primed for LD generation. Indeed, seipin has previously been proposed to
modulate PA metabolism at a ER subdomain primed for LD formation and control of
local DAG levels has been proposed to be vital for LD emergence (Cartwright et al.,
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2015; Choudhary et al., 2018; Wolinski et al., 2015). Seipin is localized at LD forming
domains during the earliest observable steps of LD formation in mammalian cells (III
and (Wang et al., 2016a)), and the hydrophobic AHs of the seipin oligomer seem well-
suited for detection of small NL aggregates between the ER leaflets (Sui et al., 2018).
In line with this, LD budding was almost completely abolished in a double yeast
mutant of seipin and the putative ER-shaping protein Pex30, with toxic levels of TAG
proposed to accumulate in the ER (Wang et al., 2018b). Remarkably, LD budding was
partially restored by modulation of the ER PL composition, suggesting that seipin and
Pex30 may normally function to regulate local PL composition of ER domains primed
for LD formation (Wang et al., 2018b). Interestingly, at least in yeast cells,
peroxisomes may also be formed at these seipin-defined subdomains (Joshi et al.,
2018; Wang et al., 2018b), suggesting seipin may modulate the organization of
lipogenic subdomains primed for both LD and peroxisome generation.
Finally, the findings in study III strongly indicate that seipin can dictate where an LD
forms, as relocalisation of seipin to a subdomain of the ER, the NE, was sufficient to
relocalize LD biogenesis to that site. However, defects in LD machinery localization
and/or lipid organization within the ER prior to LD biogenesis induction have not thus
far been observed in the absence of seipin, suggesting that at least pre-defined
subdomains required for LD assembly may not exist. Rather, the driving force for LD
biogenesis appears to be the local increases of NLs within the ER, but seipin may help
to concentrate this TAG for LD formation to occur.
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8 CONCLUSIONS AND FUTURE PROSPECTS
In this thesis, using a plethora of cell biological approaches, we sought to understand
the molecular function of seipin. Whilst advances in this field have been made by us
and others, the molecular function of seipin still remains mysterious (Gao et al., 2019;
Henne et al., 2020). Understanding seipin would greatly broaden our insight on how
cells handle excess energy in LDs and would be beneficial for developing new
therapeutics for seipin-associated diseases and other metabolic diseases owing to
altered NL storage. Furthermore, detailed insight into the basic cellular mechanisms
of LDs could also lead to advances in a wide variety of fields, including infection
control and food/oil production (Libbing et al., 2019; Pyc et al., 2017; Vieyres and
Pietschmann, 2019) .
In study I, we linked the pathogenesis of seipinopathy to NL storage, and found that
modulation of cellular NL stores could decrease ER stress. As ER stress is implicated
in the pathogenesis of multiple disease states, further investigation of the pathways by
which increasing NL storage in LDs alleviates ER stress is warranted. Indeed, new
insights into neuronal NL storage and its complex implications have been made
recently (Bailey et al., 2015; Fanning et al., 2019; Ioannou et al., 2019). Our work fits
well with the emerging notion that neuronal cells and tissues might be especially
sensitive to perturbation of cellular NL stores (Pennetta and Welte, 2018). Further
insight into the pathogenesis of seipinopathies and Celia’s encephalopathy would
benefit from both detailed structured investigations of these mutants and further in
vivo work.
In studies II-III, we investigated the function of seipin in ER-LD contact site formation
and maintenance. We found seipin to be vital for both LD biogenesis and LD
maintenance and suggest it facilitates LD growth via ER-LD contacts. Together with
recent findings from other labs (Grippa et al., 2015; Sui et al., 2018; Wang et al.,
2016a, 2018b), our data support a model where seipin defines an ER-LD contact
primed for supporting controlled LD growth. Indeed, seipin may itself structurally
limit the neck of the ER-LD contact and maintain its correct topology and function.
Seipin also appears crucial during the very earliest stages of LD biogenesis, although
we and others have yet failed to attribute this to any distinct lipid synthesis pathway.
It is tempting to speculate that seipin may attract NL molecules, such as TAG, via the
help of its ER luminal hydrophobic helices and help concentrate TAG lenses in the
ER during the very early stages of LD biogenesis. Once the LD is formed, seipin
remains at the contact, with the contact site potentially acting as a valve, releasing
TAG from the ER into the LD. Thus, in the absence of seipin, some LDs will
spontaneously bud out of the ER due to aberrantly high ER TAG concentration, as
suggested by us and others (Cartwright et al., 2015; Salo et al., 2016), whilst others
will aberrantly ripen within the ER to form supersized LDs. As the earliest stages of
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LD assembly are currently below the resolution limits of even our most powerful
microscopes, detailed simulations in combination with cell-free in vitro work would
be required to test this model further. Furthermore, understanding the native lipid
environment of seipin, perhaps using immune-purification together with sensitive
lipidomics, would greatly facilitate our understanding of the lipogenic subdomain
seipin may form.
A major unresolved issue is how stable is the conformation of the seipin oligomer in
vivo. Seipin motility in the ER is stabilized at ER-LD necks compared to its non-LD
associated cousins, but whether these seemingly different subpopulations also
experience structural alterations is unknown. Furthermore, the reason for the
decreased motility of LD-associated seipins at the molecular level is unclear.
Examination of the structures of these subpopulations separately using affinity
purification and cryo-EM, or microscopy approaches sensitive to conformational
changes, such as single molecule FRET, could be employed to investigate this further.
Our data, together with the recent structural insights into seipin and the high resolution
images of a ER-LD neck by cryo-EM (Mahamid et al., 2019; Salo et al., 2019; Sui et
al., 2018), suggest that seipin at the ER-LD neck may simultaneously be embedded in
the ER bilayer (via its TM helices) and the LD monolayer (via its luminal hydrophobic
helices and, possibly, cytoplasmic amphipathic helices), where it may form a disk-like
structure from wherein the LD buds (Figure 13). Here, the TM helices could function,
perhaps together with as-yet-unidentified interactors, to control the flow of lipids via
the ER bilayer to the LD. An intriguing notion is that at this site, seipin could
experience conformational changes induced by the alterations of the membrane
tension of the LD. In other words, “filling-up” of the LD core with NL may induce a
slight “bulging” of the LD monolayer towards the lumen, which could loosen seipin
structure so that more PLs could diffuse to the LD surface, relieving the membrane
tension. Thus, at the molecular level, seipin would function to link ER and LD PL
pools and control their trafficking according to the needs of the LD. This speculative
notion would require advanced simulations in combination with ways to measure
precisely the intracellular lipid flows at the ER-LD contact (see below).
Besides providing insight into seipin function, our work suggests that the LDs and ER
could be considered as a joint system. Lipid fluxes via the connecting ER bilayer
appear to contribute to LD-LD communication. For example, during early LD
biogenesis, NLs are likely synthesized at highly dispersed sites along the ER. Upon
rising local concentrations, a NL nucleates at a site marked by seipin and starts to
grow. The flux of NL to the growing LD, enhanced by seipin, may thus reduce nearby
TAG concentration in the ER, disfavoring the formation of other LDs nearby, as
observed in study III. Similarly, in a setting with different sized LDs connected to the
ER, seipin facilitates their growth, but upon its acute removal, the growth of the
smaller LD is disfavored. These findings suggest that adaptations of phase theory
could be utilized in future work to understand the ER-LD nexus.
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Figure 13 Proposed architecture
of seipin-mediated ER-LD contacts
and seipin function in facilitating NL
flux to LDs. Seipin oligomer is a disk
from wherein the LD buds, and it
interacts with the LD monolayer both
via luminal hydrophobic helices
(HHs) and, likely, its cytoplasmic
termini. Lower panel depicts only a
single seipin oligomer.
Precise measurements of these aforementioned lipid fluxes between the ER and LDs
would be of great interest in future work. This would require development of
additional imaging techniques, as current methodology (for example, using BPY-
labelled lipids), suffers from potential artifacts caused by the label. Label-free
techniques, such as CARS, on the other hand, currently lack the required sensitivity to
examine these minute lipid fluxes. Considering the rapid pace of advancement in
imaging and labeling techniques, such measurements will likely be possible in the near
future.
Finally, examining seipin function more closely in the context of its arguably most
important function, adipogenesis, will be of utmost importance in the future. With the
rapid advancement of CRISPR-mediated gene editing technologies and adipocyte
cultures and organoids, it would be highly interesting to observe seipin localization,
dynamics and function in developing and mature adipocytes. Indeed, adaption of the
AID technique to rapidly remove seipin at specific stages of adipogenesis or in mature
73
adipocytes would likely bring valuable insight into seipin function and adipocyte
biology. Furthermore, whilst our data suggest a single seipin foci at a forming nascent
LD, it would be interesting to examine the relationship of seipin to the giant LDs of
unilocular LDs of adipocytes. As these form via Fsp27-facilitated fusion, one would
expect multiple, perhaps even hundreds, of seipin-mediated ER-LD necks at these
LDs, but this notion has thus far not been tested experimentally. Nevertheless, as
seipin appears to be crucial in aliquoting fat between the ER and LDs, more insight
into seipin function in adipose tissue could also lead to advances in taggling one of the
most rapidly increasing epidemics of our time, obesity.
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